|
Delaware
(州或其他管辖范围
公司或组织) |
| |
6770
(主要标准工业
分类代码号) |
| |
86-2076743
(I.R.S. Employer
Identification No.) |
|
|
Andrew M. Tucker, Esq.
Larry W. Shackelford, Esq. Nelson Mullins Riley&Scarborough LLP 101 Constitution Avenue, NW Suite 900 Washington, DC 20001 (202) 689-2987 |
| |
Debbie A. Klis, Esq.
Debra Vernon, Esq. Rimon PC 1990 K Street, NW Suite 420 Washington, DC 20006 (202) 935-3390 |
|
|
Large accelerated filer
☐
|
| |
Accelerated filer
☐
|
|
|
Non-accelerated
|
| |
较小的报告公司
|
|
| | | |
Emerging growth company
|
|
|
MARKET AND INDUSTRY DATA
|
| | | | 1 | | |
|
SUMMARY TERM SHEET
|
| | | | 2 | | |
|
FREQUENTLY USED TERMS
|
| | | | 6 | | |
|
关于建议书的问答
|
| | | | 10 | | |
|
委托书/招股说明书摘要
|
| | | | 26 | | |
|
有关前瞻性陈述的警示说明
|
| | | | 40 | | |
|
数据骑士财务等数据精选
|
| | | | 42 | | |
|
ONEMEDNET精选财务等数据
|
| | | | 45 | | |
|
未经审计的备考简明合并财务信息
|
| | | | 46 | | |
|
RISK FACTORS
|
| | | | 54 | | |
|
数据骑士股东特别会议
|
| | | | 94 | | |
|
企业合并方案
|
| | | | 100 | | |
|
THE NASDAQ PROPOSAL
|
| | | | 132 | | |
|
宪章修正案提案
|
| | | | 134 | | |
|
董事竞选倡议书
|
| | | | 139 | | |
|
股权激励计划提案
|
| | | | 140 | | |
|
休会提案
|
| | | | 145 | | |
|
关于数据骑士的信息
|
| | | | 146 | | |
|
DATA KNIGHTS’ MANAGEMENT
|
| | | | 149 | | |
|
ONEMEDNET的管理
|
| | | | 183 | | |
|
市场、行业、其他数据和某些关键指标
|
| | | | 194 | | |
|
关于ONEMEDNET公司的信息
|
| | | | 154 | | |
|
ONEMEDNET的高管薪酬
|
| | | | 195 | | |
|
企业合并后的公司管理
|
| | | | 199 | | |
|
数据骑士证券介绍
|
| | | | 210 | | |
|
业务合并后的证券说明
|
| | | | 224 | | |
|
证券的实益所有权
|
| | | | 230 | | |
|
证券价格区间及分红情况
|
| | | | 232 | | |
|
APPRAISAL RIGHTS
|
| | | | 232 | | |
|
房屋寄存信息
|
| | | | 232 | | |
|
LEGAL MATTERS
|
| | | | 233 | | |
|
INDEPENDENT AUDITORS
|
| | | | 233 | | |
|
转会代理和注册商
|
| | | | 233 | | |
|
向股东交付文件
|
| | | | 233 | | |
|
提交股东建议书
|
| | | | 233 | | |
|
未来股东提案
|
| | | | 234 | | |
|
股东沟通
|
| | | | 234 | | |
|
您可以在哪里找到更多信息
|
| | | | 234 | | |
|
引用合并
|
| | | | 235 | | |
|
财务报表索引
|
| | | | F-1 | | |
|
ANNEX A – MERGER AGREEMENT
|
| | | | A-1 | | |
|
附件B - 第三次修订和重述公司注册证书
|
| | | | B-1 | | |
|
ANNEX C – 2022 EQUITY INCENTIVE PLAN
|
| | | | C-1 | | |
|
附件D - 对马歇尔和史蒂文斯的意见
|
| | | | D-1 | | |
| | |
共享数据骑士的所有权
|
| |||||||||||||||||||||||||||||||||||||||||||||
| | |
Pro Forma Combined
(Assuming No Further Redemptions Scenario) |
| |
Pro Forma Combined
(Assuming 80% Redemptions Scenario) |
| |
Pro Forma Combined
(Assuming Maximum Redemptions Scenario)(1) |
| |
Pro Forma Combined
(Assuming No Further Redemptions Scenario and Full Exercise of Options and Warrants) |
| ||||||||||||||||||||||||||||||||||||
Stockholder
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| ||||||||||||||||||||||||
OneMedNet前股东
|
| | | | 20,000,000 | | | | | | 57.5% | | | | | | 20,000,000 | | | | | | 57.5% | | | | | | 20,000,000 | | | | | | 62.7% | | | | | | 20,806,453 | | | | | | 51.0% | | |
Data Knights Public Stockholders(2)(4)
|
| | | | 2,731,544 | | | | | | 7.9% | | | | | | 2,300,000 | | | | | | 6.6% | | | | | | — | | | | | | —% | | | | | | 6,884,322 | | | | | | 18.6% | | |
Data Knights Sponsor
and Insiders(3) |
| | | | 7,018,161 | | | | | | 20.2% | | | | | | 6,910,275 | | | | | | 19.9% | | | | | | 6,335,275 | | | | | | 19.9% | | | | | | 7,581,123 | | | | | | 16.2% | | |
PIPE and Others
|
| | | | 5,015,485 | | | | | | 14.4% | | | | | | 5,563,514 | | | | | | 16.0% | | | | | | 5,563,514 | | | | | | 17.4% | | | | | | 5,563,514 | | | | | | 14.8% | | |
Total Shares Outstanding
|
| | | | 34,765,190 | | | | | | 100.0% | | | | | | 34,773,789 | | | | | | 100.0% | | | | | | 31,898,789 | | | | | | 100.0% | | | | | | 40,835,412 | | | | | | 100.0% | | |
Stockholder
|
| |
共享数据骑士的所有权
|
| |||||||||||||||||||||||||||||||||
|
Pro Forma Combined
(Assuming No Further Redemptions Scenario) |
| |
Pro Forma Combined
(Assuming 80% Redemptions Scenario) |
| |
Pro Forma Combined
(Assuming Maximum Redemptions Scenario)(1) |
| |||||||||||||||||||||||||||||
|
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| ||||||||||||||||||||
Former OMN equity holders
|
| | | | 20,806,453 | | | | | | 51.0% | | | | | | 20,806,453 | | | | | | 51.6% | | | | | | 20,806,453 | | | | | | 55.6% | | |
OMN equity holders
|
| | | | 20,000,000 | | | | | | 49.0% | | | | | | 20,000,000 | | | | | | 49.6% | | | | | | 20,000,000 | | | | | | 53.4% | | |
持有未偿还期权的人
|
| | | | 806,453 | | | | | | 2.0% | | | | | | 806,453 | | | | | | 2.0% | | | | | | 806,453 | | | | | | 2.2% | | |
数据骑士公共股东
|
| | | | 6,884,322 | | | | | | 16.9% | | | | | | 6,452,778 | | | | | | 16.0% | | | | | | 4,152,778 | | | | | | 11.1% | | |
IPO Public Shares
|
| | | | 2,731,544 | | | | | | 6.7% | | | | | | 2,300,000 | | | | | | 5.7% | | | | | | — | | | | | | 0.0% | | |
Public Warrants
|
| | | | 4,152,778 | | | | | | 10.2% | | | | | | 4,152,778 | | | | | | 10.3% | | | | | | 4,152,778 | | | | | | 11.1% | | |
数据骑士赞助商和内部人士
|
| | | | 7,851,123 | | | | | | 18.6% | | | | | | 7,473,237 | | | | | | 18.5% | | | | | | 6,898,237 | | | | | | 18.4% | | |
Shares
|
| | | | 7,219.774 | | | | | | 17.7% | | | | | | 7,111,888 | | | | | | 17.6% | | | | | | 6,536,888 | | | | | | 17.5% | | |
私募认股权证
|
| | | | 211,349 | | | | | | 0.5% | | | | | | 211,349 | | | | | | 0.5% | | | | | | 211,349 | | | | | | 0.6% | | |
转换工作的授权书
capital loan |
| | | | 150,000 | | | | | | 0.4% | | | | | | 150,000 | | | | | | 0.4% | | | | | | 150,000 | | | | | | 0.4% | | |
PIPE
|
| | | | 3,000,000 | | | | | | 7.3% | | | | | | 3,000,000 | | | | | | 7.4% | | | | | | 3,000,000 | | | | | | 8.0% | | |
Equity Incentive Plan
|
| | | | 360,000 | | | | | | 0.9% | | | | | | 360,000 | | | | | | 0.9% | | | | | | 360,000 | | | | | | 1.0% | | |
ARC Group Ltd
|
| | | | 2,203,514 | | | | | | 5.4% | | | | | | 2,203,514 | | | | | | 5.5% | | | | | | 2,203,514 | | | | | | 5.9% | | |
Total
|
| | | | 40,835,412 | | | | | | 100.0% | | | | | | 40,295,982 | | | | | | 100.0% | | | | | | 37,420,982 | | | | | | 100.0% | | |
| | |
不行使期权和认股权证
|
| |
充分行使期权和认股权证
|
| ||||||||||||||||||||||||||||||
| | |
No Further
Redemptions |
| |
80%
Redemptions |
| |
Maximum
Redemptions |
| |
No Further
Redemptions |
| |
80%
Redemptions |
| |
Maximum
Redemptions |
| ||||||||||||||||||
管道每股权益价值
|
| | | $ | 7.01 | | | | | $ | 6.88 | | | | | $ | 6.74 | | | | | $ | 5.97 | | | | | $ | 5.94 | | | | | $ | 5.75 | | |
不含管道的每股权益值
|
| | | $ | 6.73 | | | | | $ | 6.59 | | | | | $ | 6.40 | | | | | $ | 5.65 | | | | | $ | 5.61 | | | | | $ | 5.37 | | |
Security
|
| |
Shares
|
| |
Current
Estimated Value Per Share |
| |
Current
Estimated Value |
| |
Initial
Cost |
| |
Unrealized
Profit |
| |
Unrealized
Profit Per Share |
| ||||||||||||||||||
Founder Shares
|
| | | | 6,432,886 | | | | | $ | 10.49 | | | | | $ | 67,480,974 | | | | | $ | 25,000 | | | | | $ | 67,455,974 | | | | | $ | 10.49 | | |
Placement Units
|
| | | | 525,275 | | | | | $ | 10.49 | | | | | $ | 5,510,135 | | | | | $ | 5,252,750 | | | | | $ | 257,385 | | | | | $ | 0.49 | | |
私募认股权证
|
| | | | 525,275 | | | | | $ | 0.06 | | | | | $ | 32,775 | | | | | $ | — | | | | | $ | 32,775 | | | | | $ | 0.06 | | |
流动资金贷款转换权证
|
| | | | 150,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 9,359 | | | | | $ | 0.06 | | |
Total/Weighted Average
|
| | | | 7,633,436 | | | | | $ | 9.57 | | | | | $ | 73,023,884 | | | | | $ | 5,277,750 | | | | | $ | 67,755,493 | | | | | $ | 8.88 | | |
Security
|
| |
Shares
|
| |
Current
Estimated Value Per Share |
| |
Current
Estimated Value |
| |
Initial
Cost |
| |
Unrealized
Profit |
| |
Unrealized
Profit Per Share |
| ||||||||||||||||||
Founder Shares
|
| | | | 6,325,000 | | | | | $ | 10.49 | | | | | $ | 66,349,250 | | | | | $ | 25,000 | | | | | $ | 66,324,250 | | | | | $ | 10.49 | | |
Placement Units
|
| | | | 525,275 | | | | | $ | 10.49 | | | | | $ | 5,510,135 | | | | | $ | 5,252,750 | | | | | $ | 257,385 | | | | | $ | 0.49 | | |
私募认股权证
|
| | | | 525,275 | | | | | $ | 0.06 | | | | | $ | 32,775 | | | | | $ | — | | | | | $ | 32,775 | | | | | $ | 0.06 | | |
流动资金贷款转换权证
|
| | | | 150,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 9,359 | | | | | $ | 0.06 | | |
Total/Weighted Average
|
| | | | 7,525,550 | | | | | $ | 9.55 | | | | | $ | 71,892,160 | | | | | $ | 5,277,750 | | | | | $ | 66,623,769 | | | | | $ | 8.85 | | |
Security
|
| |
Shares
|
| |
Current
Estimated Value Per Share |
| |
Current
Estimated Value |
| |
Initial
Cost |
| |
Unrealized
Profit |
| |
Unrealized
Profit Per Share |
| ||||||||||||||||||
Founder Shares
|
| | | | 5,750,000 | | | | | $ | 10.49 | | | | | $ | 60,317,500 | | | | | $ | 25,000 | | | | | $ | 60,292,500 | | | | | $ | 10.49 | | |
Placement Units
|
| | | | 525,275 | | | | | $ | 10.49 | | | | | $ | 5,510,135 | | | | | $ | 5,252,750 | | | | | $ | 257,385 | | | | | $ | 0.49 | | |
私募认股权证
|
| | | | 525,275 | | | | | $ | 0.06 | | | | | $ | 32,775 | | | | | $ | — | | | | | $ | 32,775 | | | | | $ | 0.06 | | |
流动资金贷款转换权证
|
| | | | 150,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 9,359 | | | | | $ | 0.06 | | |
Total/Weighted Average
|
| | | | 6,950,550 | | | | | $ | 9.48 | | | | | $ | 65,860,410 | | | | | $ | 5,277,750 | | | | | $ | 60,592,019 | | | | | $ | 8.72 | | |
Name
|
| |
Age
|
| |
Position
|
|
Paul Casey | | |
76
|
| | 董事首席执行官(5) | |
Dr. Jeffrey Yu | | |
55
|
| | 董事会主席、创始人、首席医疗官总裁副董事长(6) | |
Lisa Embree | | |
51
|
| | - 财务副总裁总裁首席财务官 | |
Erkan Akyuz | | |
53
|
| | Director(1)(2)(4) | |
Eric Casaburi | | |
48
|
| | Director(4) | |
Robert Golden | | |
60
|
| | Director(1)(2)(6) | |
Dr. Julianne Huh | | |
53
|
| | Director(3)(4) | |
Dr. Thomas Kosasa | | |
77
|
| | Director(1)(5) | |
Dr. Christoph Zindel | | |
61
|
| | Director(2)(3)(6) | |
Security
|
| |
Shares
|
| |
Current
Estimated Value Per Share |
| |
Current
Estimated Value |
| |
Initial
Cost |
| |
Unrealized
Profit |
| |
Unrealized
Profit Per Share |
| ||||||||||||||||||
Founder Shares
|
| | | | 6,432,886 | | | | | $ | 10.49 | | | | | $ | 67,480,974 | | | | | $ | 25,000 | | | | | $ | 67,455,974 | | | | | $ | 10.49 | | |
Placement Units
|
| | | | 525,275 | | | | | $ | 10.49 | | | | | $ | 5,510,135 | | | | | $ | 5,252,750 | | | | | $ | 257,385 | | | | | $ | 0.49 | | |
私募认股权证
|
| | | | 525,275 | | | | | $ | 0.06 | | | | | $ | 32,775 | | | | | $ | — | | | | | $ | 32,775 | | | | | $ | 0.06 | | |
流动资金贷款转换权证
|
| | | | 150,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 9,359 | | | | | $ | 0.06 | | |
总计/加权平均值
|
| | | | 7,633,436 | | | | | $ | 9.57 | | | | | $ | 73,023,884 | | | | | $ | 5,277,750 | | | | | $ | 67,755,493 | | | | | $ | 8.88 | | |
Security
|
| |
Shares
|
| |
Current
Estimated Value Per Share |
| |
Current
Estimated Value |
| |
Initial
Cost |
| |
Unrealized
Profit |
| |
Unrealized
Profit Per Share |
| ||||||||||||||||||
Founder Shares
|
| | | | 6,325,000 | | | | | $ | 10.49 | | | | | $ | 66,349,250 | | | | | $ | 25,000 | | | | | $ | 66,324,250 | | | | | $ | 10.49 | | |
Placement Units
|
| | | | 525,275 | | | | | $ | 10.49 | | | | | $ | 5,510,135 | | | | | $ | 5,252,750 | | | | | $ | 257,385 | | | | | $ | 0.49 | | |
私募认股权证
|
| | | | 525,275 | | | | | $ | 0.06 | | | | | $ | 32,775 | | | | | $ | — | | | | | $ | 32,775 | | | | | $ | 0.06 | | |
流动资金贷款转换权证
|
| | | | 150,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 9,359 | | | | | $ | 0.06 | | |
总计/加权平均值
|
| | | | 7,525,550 | | | | | $ | 9.55 | | | | | $ | 71,892,160 | | | | | $ | 5,277,750 | | | | | $ | 66,623,769 | | | | | $ | 8.85 | | |
Security
|
| |
Shares
|
| |
Current
Estimated Value Per Share |
| |
Current
Estimated Value |
| |
Initial
Cost |
| |
Unrealized
Profit |
| |
Unrealized
Profit Per Share |
| ||||||||||||||||||
Founder Shares
|
| | | | 5,750,000 | | | | | $ | 10.49 | | | | | $ | 60,317,500 | | | | | $ | 25,000 | | | | | $ | 60,292,500 | | | | | $ | 10.49 | | |
Placement Units
|
| | | | 525,275 | | | | | $ | 10.49 | | | | | $ | 5,510,135 | | | | | $ | 5,252,750 | | | | | $ | 257,385 | | | | | $ | 0.49 | | |
私募认股权证
|
| | | | 525,275 | | | | | $ | 0.06 | | | | | $ | 32,775 | | | | | $ | — | | | | | $ | 32,775 | | | | | $ | 0.06 | | |
流动资金贷款转换权证
|
| | | | 150,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 9,359 | | | | | $ | 0.06 | | |
总计/加权平均值
|
| | | | 6,950,550 | | | | | $ | 9.48 | | | | | $ | 65,860,410 | | | | | $ | 5,277,750 | | | | | $ | 60,592,019 | | | | | $ | 8.72 | | |
| | |
(Unaudited)
For the Nine Month Period ended September 30, 2022 |
| |
For the Period
from February 8, 2021 (Inception) through September 30, 2021 |
| ||||||
组建和运营成本
|
| | | $ | 1,771,902 | | | | | $ | 170,064 | | |
Franchise tax expenses
|
| | | | 152,802 | | | | | | — | | |
Loss from Operations
|
| | | | 1,924,704 | | | | | | (170,064) | | |
Other Income (Expenses) | | | | | | | | | | | | | |
已实现和未实现收益
|
| | | | 779,706 | | | | | | 3,961 | | |
权证负债公允价值变动
|
| | | | 4,243,893 | | | | | | 6,391,703 | | |
Non-operating expense
|
| | | | — | | | | | | (625,059) | | |
Net Income (loss)
|
| | | $ | 2,992,171 | | | | | $ | 5,600,271 | | |
A类普通股赎回加权平均流通股
|
| | | | 11,500,000 | | | | | | 6,997,872 | | |
普通股基本和稀释后净收益
|
| | | $ | 0.20 | | | | | $ | 0.55 | | |
A类和B类不可赎回普通股加权平均流通股
|
| | | | 3,460,275 | | | | | | 3,231,146 | | |
普通股基本和稀释后净收益
|
| | | $ | 0.20 | | | | | $ | 0.55 | | |
| | |
(Unaudited)
For the Nine- Month Period ended September 30, 2022 |
| |
For the Period
from February 8, 2021 (Inception) through September 30, 2021 |
| ||||||
经营活动现金流: | | | | | | | | | | | | | |
Net income
|
| | | $ | 2,992,171 | | | | | $ | 4,307,307 | | |
将净收入与经营活动中使用的净现金进行调整:
|
| | | | | | | | | | | | |
分配给认股权证负债的报价成本
|
| | | | — | | | | | | 625,059 | | |
已实现和未实现收益
|
| | | | (779,706) | | | | | | (794) | | |
权证负债公允价值变动
|
| | | | (4,243,893) | | | | | | (6,391,703) | | |
经营性资产和负债变动: | | | | | | | | | | | | | |
Prepaid expense
|
| | | | 83,061 | | | | | | (10,000) | | |
Accrued expense
|
| | | | 1,159,114 | | | | | | 51,811 | | |
Franchise tax payable
|
| | | | (114,008) | | | | | | — | | |
Income tax payable
|
| | | | 106,724 | | | | | | — | | |
经营活动中使用的净现金
|
| | | | (796,537) | | | | | | (297,932) | | |
信托账户现金投资
|
| | | | (2,300,000) | | | | | | (117,300,000) | | |
从信托账户提取利息
|
| | | | 266,809 | | | | | | — | | |
投资活动中使用的净现金
|
| | | | (2,033,191) | | | | | | (117,300,000) | | |
向保荐人发行B类普通股所得款项
|
| | | | — | | | | | | 25,000 | | |
出售公共单位的收益,扣除承保折扣后的净额
paid |
| | | | — | | | | | | 112,700,000 | | |
出售私募单位的收益
|
| | | | — | | | | | | 5,852,750 | | |
Payment of offering costs
|
| | | | — | | | | | | (446,112) | | |
营运资金贷款收益
|
| | | | 300,000 | | | | | | — | | |
应付关联方金额
|
| | | | 11,500 | | | | | | — | | |
延期贷款收益
|
| | | | 2,300,000 | | | | | | — | | |
融资活动提供的现金净额
|
| | | | 2,611,500 | | | | |
|
118,131,638
|
| |
Net change in cash
|
| | | | (218,228) | | | | | | 533,706 | | |
期初现金
|
| | | | 453,151 | | | | | | — | | |
Cash at the end of the period
|
| | |
$
|
234,921
|
| | | | $ | 533,706 | | |
补充披露非现金融资活动: | | | | | | | | | | | | | |
可能赎回的A类普通股初始分类
|
| | | $ | — | | | | | $ | 117,300,000 | | |
可能赎回的普通股价值变动
|
| | | $ | 2,833,869 | | | | | $ | — | | |
应付延期承销费
|
| | | $ | — | | | | | $ | 4,025,000 | | |
权证责任的初始分类
|
| | | $ | — | | | | |
$
|
11,176,949
|
| |
| | |
September 30,
2022 |
| |
December 31,
2021 |
| ||||||
ASSETS
|
| |
(Unaudited)
|
| | | | | | | |||
Current Assets | | | | | | | | | | | | | |
Cash
|
| | | $ | 234,923 | | | | | $ | 453,151 | | |
Prepaid expense
|
| | | | — | | | | | | 21,215 | | |
Prepaid insurance
|
| | | | — | | | | | | 61,846 | | |
Total Current Assets
|
| | | $ | 234,923 | | | | | $ | 536,212 | | |
信托账户中持有的投资
|
| | | | 120,133,869 | | | | | | 117,320,973 | | |
Total Assets
|
| | | $ | 120,368,792 | | | | | $ | 117,857,185 | | |
负债和股东权益 | | | | | | | | | | | | | |
Current liabilities
|
| | | | | | | | | | | | |
Accrued expense
|
| | | $ | 1,285,086 | | | | | $ | 125,972 | | |
应付关联方金额
|
| | | | 11,500 | | | | | | — | | |
Income tax payable
|
| | | | 106,724 | | | | | | — | | |
Franchise tax payable
|
| | | | 50,000 | | | | | | 164,008 | | |
流动负债总额
|
| | | | 1,453,310 | | | | | | 289,980 | | |
Warrant liabilities
|
| | | | 607,775 | | | | | | 4,851,668 | | |
应付延期承销费
|
| | | | 4,025,000 | | | | | | 4,025,000 | | |
Working capital loan
|
| | | | 300,000 | | | | | | — | | |
Extension loan
|
| | | | 2,300,000 | | | | | | — | | |
Total Liabilities
|
| | | | 8,686,085 | | | | | | 9,166,648 | | |
承付款和或有事项 | | | | | | | | | | | | | |
可能赎回的A类普通股;1,500,000
截至9月30日,赎回价值为10.40美元和10.20美元的股票 2022 and December 31, 2021, respectively |
| | | | 120,133,869 | | | | | | 117,300,000 | | |
Stockholders’ Deficit | | | | | | | | | | | | | |
优先股,面值0.0001美元;授权1,000,000股;无
issued and outstanding |
| | | | — | | | | | | — | | |
A类普通股,面值0.0001美元;授权发行1亿股;已发行和已发行股票585,275股,不包括需要赎回的11,500,000股
|
| | | | 59 | | | | | | 59 | | |
B类普通股,面值0.0001美元;授权发行1,000万股;已发行和已发行股票2,875,000股
|
| | | | 288 | | | | | | 288 | | |
Additional paid-in capital
|
| | | | — | | | | | | — | | |
Accumulated deficit
|
| | | | (8,451,509) | | | | | | (8,609,810) | | |
Total Stockholders’ Deficit
|
| | | | (8,451,162) | | | | | | (8,609,463) | | |
总负债和股东亏损
|
| | | $ | 120,368,772 | | | | | $ | 117,857,185 | | |
Statement of Operation Data:
|
| |
For the Three Months
Ended September 30, |
| |
For the Year Ended December 31,
|
| ||||||||||||
|
2022
|
| |
2021
|
| |
2020
|
| |||||||||||
| | |
(unaudited)
|
| |
(audited)
|
| ||||||||||||
Revenue, net
|
| | | $ | 375,092 | | | | | $ | 1,091,777 | | | | | $ | 824,034 | | |
Cost of goods sold
|
| | | | 473,949 | | | | | | 1,205,184 | | | | | | 611,662 | | |
Gross profit (loss)
|
| | | | (98,857) | | | | | | (113,407) | | | | | | 212,372 | | |
Operating expenses | | | | | | | | | | | | | | | | | | | |
Sales and marketing
|
| | | | 257,231 | | | | | | 605,235 | | | | | | 318,407 | | |
一般和行政
|
| | | | 748,647 | | | | | | 1,196,712 | | | | | | 2,064,206 | | |
Operations
|
| | | | 141,807 | | | | | | 152,461 | | | | | | 454,606 | | |
Research and development
|
| | | | 336,007 | | | | | | 642,765 | | | | | | 307,272 | | |
Total operating expenses
|
| | | | 1,483,692 | | | | | | 2,597,173 | | | | | | 3,144,491 | | |
Operating loss
|
| | | | (1,582,549) | | | | | | (2,710,580) | | | | | | (2,932,119) | | |
Other income (expense) | | | | | | | | | | | | | | | | | | | |
Interest expense, net
|
| | | | 108,526 | | | | | | (195,381) | | | | | | (193,549) | | |
Other income (expense)
|
| | | | 9,641 | | | | | | (34,905) | | | | | | 82,997 | | |
Income (Loss) before income tax
|
| | | | 118,167 | | | | | | 230,286 | | | | | | 110,552 | | |
Net loss
|
| | | $ | (1,700,716) | | | | | $ | (2,940,866) | | | | | $ | (2,821,567) | | |
Balance Sheet Data:
|
| |
As of
September 30, |
| |
As of
December 31, |
| ||||||||||||
|
2022
|
| |
2021
|
| |
2020
|
| |||||||||||
| | |
(unaudited)
|
| |
(audited)
|
| ||||||||||||
Total assets
|
| | | $ | 683,479 | | | | | $ | 883,060 | | | | | $ | 327,914 | | |
Total liabilities
|
| | | $ | 10,390,397 | | | | | $ | 6,585,672 | | | | | $ | 3,187,531 | | |
Total stockholders’ deficit
|
| | | $ | (9,706,918) | | | | | $ | (5,702,612) | | | | | $ | (2,859,617) | | |
| | |
OneMedNet
(Historical) |
| |
Data Knights
(Historical) |
| |
Pro Forma
Adjustments Assuming Minimum (Historical) |
| | | | |
Pro Forma
Combined Assuming Minimum Redemption |
| |
Pro Forma
Adjustments Assuming Maximum Redemption |
| | | | | | | |
Pro Forma
Combined Assuming Maximum Redemption |
| ||||||||||||||||||
ASSETS
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Current assets:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 312 | | | | | $ | 235 | | | | | $ | 120,134 | | | |
A
|
| | | $ | 151,756 | | | | | | (120,134) | | | | | | I | | | | | | 31,622 | | |
| | | | | | | | | | | | | | | | | (4,025) | | | |
B
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | (900) | | | |
C
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | 36,000 | | | |
J
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Accounts receivable
|
| | | | 180 | | | | | | | | | | | | | | | | | | | | | 180 | | | | | | | | | | | | | | | | | | 180 | | |
预付费用和其他流动资产
|
| | | | 109 | | | | | | | | | | | | | | | | | | | | | 109 | | | | | | | | | | | | | | | | | | 109 | | |
Total current assets
|
| | | | 601 | | | | | | 235 | | | | | | 151,209 | | | | | | | | | 152,045 | | | | | | (120,134) | | | | | | | | | | | | 31,911 | | |
Non-current assets:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Prepaid expenses
|
| | | | | | | | | | | | | | | | | | | | | | | | | — | | | | | | | | | | | | | | | | | | — | | |
信托账户中持有的现金和有价证券
|
| | | | | | | | | | 120,134 | | | | | | (120,134) | | | |
A
|
| | | | — | | | | | | | | | | | | | | | | | | — | | |
Property and equipment, net
|
| | | | 82 | | | | | | | | | | | | | | | | | | | | | 82 | | | | | | | | | | | | | | | | | | 82 | | |
Total non-current assets
|
| | | | 82 | | | | | | 120,134 | | | | | | (120,134) | | | | | | | |
|
82
|
| | | | | — | | | | | | | | | | |
|
82
|
| |
TOTAL ASSETS
|
| | | | 683 | | | | | | 120,369 | | | | | | 31,075 | | | | | | | | | 152,127 | | | | | | (120,134) | | | | | | | | | | | | 31,993 | | |
负债、临时权益和股东权益(亏损)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
应付账款和应计费用
|
| | | | 1,000 | | | | | | 1,285 | | | | | | | | | | | | | | | 2,285 | | | | | | | | | | | | | | | | | | 2,285 | | |
Amount due related party
|
| | | | | | | | | | 12 | | | | | | | | | | | | | | | 12 | | | | | | | | | | | | | | | | | | 12 | | |
Income taxes payable
|
| | | | | | | | | | 107 | | | | | | | | | | | | | | | 107 | | | | | | | | | | | | | | | | | | 107 | | |
Franchise tax payable
|
| | | | | | | | | | 50 | | | | | | | | | | | | | | | 50 | | | | | | | | | | | | | | | | | | 50 | | |
Deferred revenues
|
| | | | 335 | | | | | | | | | | | | | | | | | | | | | 335 | | | | | | | | | | | | | | | | | | 335 | | |
可转换本票
|
| | | | 6,950 | | | | | | | | | | | | | | | | | | | | | 6,950 | | | | | | | | | | | | | | | | | | 6,950 | | |
Total current liabilities
|
| | | | 8,285 | | | | | | 1,454 | | | | | | — | | | | | | | | | 9,739 | | | | | | | | | | | | | | | | | | 9,739 | | |
Non-current liabilities:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
《加拿大能源商业贷款法案》
|
| | | | 45 | | | | | | | | | | | | | | | | | | | | | 45 | | | | | | | | | | | | | | | | | | 45 | | |
应计利息,关联方
|
| | | | 560 | | | | | | | | | | | | | | | | | | | | | 560 | | | | | | | | | | | | | | | | | | 560 | | |
Derivative liability
|
| | | | | | | | | | 608 | | | | | | | | | | | | | | | 608 | | | | | | | | | | | | | | | | | | 608 | | |
应付延期承销费
|
| | | | | | | | | | 4,025 | | | | | | (4,025) | | | |
B
|
| | | | — | | | | | | | | | | | | | | | | | | — | | |
Extension loan
|
| | | | | | | | | | 2,300 | | | | | | | | | | | | | | | 2,300 | | | | | | | | | | | | | | | | | | 2,300 | | |
Working capital loan
|
| | | | | | | | | | 300 | | | | | | | | | | | | | | | 300 | | | | | | | | | | | | | | | | | | 300 | | |
可转换本票
|
| | | | 1,500 | | | | | | | | | | | | | | | | | | | | | 1,500 | | | | | | | | | | | | | | | | | | 1,500 | | |
非流动负债合计
|
| | | | 2,105 | | | | | | 7,233 | | | | | | (4,025) | | | | | | | | | 5,313 | | | | | | — | | | | | | | | | | | | 5,313 | | |
Total liabilities
|
| | |
|
10,390
|
| | | |
|
8,687
|
| | | |
|
(4,025)
|
| | | | | | |
|
15,052
|
| | | |
|
—
|
| | | | | | | | | |
|
15,052
|
| |
承付款和或有事项
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Temporary equity:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
可能赎回的A类和B类普通股
|
| | | | | | | | | | 120,134 | | | | | | (120,134) | | | |
D
|
| | | | — | | | | | | | | | | | | | | | | | | — | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | — | | |
Stockholders’ equity (deficit):
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | — | | |
Preferred Series A-2
|
| | | | | | | | | | | | | | | | — | | | |
E
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Perferred Series A-1
|
| | | | | | | | | | | | | | | | — | | | |
E
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Common stock
|
| | | | | | | | | | | | | | | | 2 | | | |
F
|
| | | | 3 | | | | | | (1) | | | | | | I | | | | | | 2 | | |
| | | | | | | | | | | | | | | | | 1 | | | |
D
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | — | | | |
E
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Class A common stock
|
| | | | | | | | | | — | | | | | | — | | | |
G
|
| | | | | | | | | | | | | | | | | | | | | | — | | |
Class B common stock
|
| | | | | | | | | | — | | | | | | — | | | |
G
|
| | | | — | | | | | | | | | | | | | | | | | | — | | |
Additional paid-in capital
|
| | | | 19,660 | | | | | | — | | | | | | 120,133 | | | |
D
|
| | | | 166,439 | | | | | | (120,133) | | | | | | I | | | | | | 46,306 | | |
| | | | | | | | | | | | | | | | | (2) | | | |
F
|
| | | | | | | | | | | | | | | | | | | | | | — | | |
| | | | | | | | | | | | | | | | | (8,452) | | | |
H
|
| | | | | | | | | | | | | | | | | | | | | | — | | |
| | | | | | | | | | | | | | | | | (900) | | | |
C
|
| | | | | | | | | | | | | | | | | | | | | | — | | |
| | | | | | | | | | | | | | | | | 36,000 | | | |
J
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Accumulated deficit
|
| | | | (29,367) | | | | | | (8,452) | | | | | | 8,452 | | | |
H
|
| | | | (29,367) | | | | | | | | | | | | | | | | | | (29,367) | | |
股东权益合计(亏损)
|
| | |
|
(9,707)
|
| | | |
|
(8,452)
|
| | | |
|
155,234
|
| | | | | | |
|
137,075
|
| | | |
|
(120,134)
|
| | | | | | | | | |
|
16,941
|
| |
总负债、临时权益和股东亏损
|
| | | | 683 | | | | | | 120,369 | | | | | | 31,075 | | | | | | | | | 152,127 | | | | | | (120,134) | | | | | | | | | | | | 31,993 | | |
| | |
OneMedNet
(Historical) |
| |
Data Knights
(Historical) |
| |
Pro Forma
Adjustments Assuming Minimum and Maximum Redemption |
| | | | | | | |
Pro Forma
Combined Assuming Minimum and Maximum Redemption |
| ||||||||||||
Revenues
|
| | | $ | 889 | | | | | $ | — | | | | | $ | — | | | | | | | | | | | $ | 889 | | |
Cost of revenue
|
| | | | 1,106 | | | | | | — | | | | | | — | | | | | | | | | | | | 1,106 | | |
Gross profit
|
| | | | (217) | | | | | | — | | | | | | — | | | | | | | | | | | | (217) | | |
运营成本和费用: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
销售、一般和行政费用
|
| | | | 3,537 | | | | | | 1,925 | | | | | | | | | | | | | | | | | | 5,462 | | |
总运营成本和费用
|
| | | | 3,537 | | | | | | 1,925 | | | | | | — | | | | | | | | | | | | 5,462 | | |
Loss from operations
|
| | |
|
(3,754)
|
| | | |
|
(1,925)
|
| | | |
|
—
|
| | | | | | | | | | | (5,679) | | |
Other income (expense): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense
|
| | | | (273) | | | | | | — | | | | | | | | | | | | | | | | | | (273) | | |
衍生负债公允价值变动
|
| | | | | | | | | | 4,244 | | | | | | — | | | | | | | | | | | | 4,244 | | |
Other income (expense)
|
| | | | (30) | | | | | | | | | | | | | | | | | | | | | | | | | | |
信托的已实现和未实现收益
Account |
| | | | | | | | | | 780 | | | | | | (780) | | | | | | BB | | | | | | — | | |
Total other income (expense)
|
| | |
|
(303)
|
| | | |
|
5,024
|
| | | |
|
(780)
|
| | | | | | | | | | | 3,941 | | |
扣除所得税准备前的净收益(亏损)
|
| | | | (4,057) | | | | | | 3,099 | | | | | | (780) | | | | | | | | | | | | (1,738) | | |
Income tax provision
|
| | | | — | | | | | | (107) | | | | | | — | | | | | | | | | | |
|
(107)
|
| |
Net income (loss)
|
| | | | (4,057) | | | | | | 2,992 | | | | | | (780) | | | | | | | | | | | | (1,845) | | |
| | |
OneMedNet
(Historical) |
| |
Data Knights
(Historical) |
| |
Assuming
Minimum Redemption |
| |
Assuming
Maximum Redemption |
| ||||||||||||
加权平均流通股 - 普通股
|
| | | | 4,342,666 | | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
基本和稀释后每股净收入 - 普通股
|
| | | | (0.93) | | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
需要赎回的加权平均流通股 - A类和B类普通股
|
| | | | — | | | | | | 11,500,000 | | | | | | 34,960,275 | | | | | | 23,460,275 | | |
基本和稀释后每股净收入 - A类和
需要赎回的B类普通股 |
| | | | — | | | | | | 0.20 | | | | | | (0.05) | | | | | | (0.08) | | |
加权平均流通股 - A类和B类不可赎回普通股
|
| | | | — | | | | | | 3,460,275 | | | | | | — | | | | | | — | | |
基本和稀释后每股净收入 - A类和
B类不可赎回普通股 |
| | | | — | | | | | | 0.20 | | | | | | — | | | | | | — | | |
| | |
OneMedNet
(Historical) |
| |
Data Knights
(Historical) |
| |
Pro Forma
Adjustments Assuming Minimum and Maximum Redemption |
| | | | | | | |
Pro Forma
Combined Assuming Minimum and Maximum Redemption |
| ||||||||||||
Revenues
|
| | | $ | 1,092 | | | | | $ | — | | | | | $ | — | | | | | | | | | | | $ | 1,092 | | |
Cost of revenue
|
| | | | 1,205 | | | | | | — | | | | | | — | | | | | | | | | | | | 1,205 | | |
Gross profit
|
| | | | (113) | | | | | | — | | | | | | — | | | | | | | | | | | | (113) | | |
运营成本和费用: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
销售、一般和行政费用
|
| | | | 2,597 | | | | | | 585 | | | | | | 2,800 | | | | | | AA型 | | | | | | 5,982 | | |
总运营成本和费用
|
| | | | 2,597 | | | | | | 585 | | | | | | 2,800 | | | | | | | | | | | | 5,982 | | |
Loss from operations
|
| | |
|
(2,710)
|
| | | |
|
(585)
|
| | | |
|
(2,800)
|
| | | | | | | | | | | (6,095) | | |
Other income (expense): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense
|
| | | | (195) | | | | | | | | | | | | — | | | | | | | | | | | | (195) | | |
衍生负债公允价值变动
|
| | | | | | | | | | 6,325 | | | | | | — | | | | | | | | | | | | 6,325 | | |
计入权证责任的要约成本
|
| | | | | | | | | | (625) | | | | | | | | | | | | | | | | | | | | |
Other income (expense)
|
| | | | (35) | | | | | | | | | | | | | | | | | | | | | | | | | | |
信托账户已实现和未实现收益
|
| | | | | | | | | | 19 | | | | | | (19) | | | | | | 抄送 | | | | | | — | | |
信托账户利息收入
|
| | | | | | | | | | 2 | | | | | | (2) | | | | | | BB | | | | | | — | | |
Total other income (expense)
|
| | |
|
(230)
|
| | | |
|
5,721
|
| | | |
|
(21)
|
| | | | | | | | | | | 5,470 | | |
扣除所得税准备前的净收益(亏损)
|
| | | | (2,940) | | | | | | 5,136 | | | | | | (2,821) | | | | | | | | | | | | (625) | | |
Income tax provision
|
| | | | | | | | | | | | | | | | | | | | | | | | | | |
|
—
|
| |
Net income (loss)
|
| | | | (2,940) | | | | | | 5,136 | | | | | | (2,821) | | | | | | | | | | | | (625) | | |
| | |
OneMedNet
(Historical) |
| |
Data Knights
(Historical) |
| |
Assuming
Minimum Redemption |
| |
Assuming
Maximum Redemption |
| ||||||||||||
加权平均流通股 - 普通股
|
| | | | 4,342,666 | | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
基本和稀释后每股净收入 - 普通股
|
| | | | (0.68) | | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
需要赎回的加权平均流通股 - A类和B类普通股
|
| | | | — | | | | | | 8,264,526 | | | | | | 34,960,275 | | | | | | 23,460,275 | | |
基本和稀释后每股净收入 - A类和
需要赎回的B类普通股 |
| | | | — | | | | | | 0.44 | | | | | | (0.02) | | | | | | (0.03) | | |
加权平均流通股 - A类和B类不可赎回普通股
|
| | | | — | | | | | | 3,295,610 | | | | | | — | | | | | | — | | |
基本和稀释后每股净收入 - A类和
B类不可赎回普通股 |
| | | | — | | | | | | 0.44 | | | | | | — | | | | | | — | | |
| | |
OneMedNet
Historical |
| |
Data
Knights Historical |
| |
Minimum
Redemption |
| |
33.33% of
Maximum Redemption |
| |
50% of
Maximum Redemption |
| |
66.67% of
Maximum Redemption |
| |
Maximum
Redemption |
| |||||||||||||||||||||
September 30, 2022 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
需要赎回的加权平均流通股 - A类和B类普通股
|
| | | | (0.93) | | | | | | 11,500,000 | | | | | | 34,960,275 | | | | | | 31,127,325 | | | | | | 29,210,275 | | | | | | 27,293,225 | | | | | | 23,460,275 | | |
每单位的基本和稀释后净收入
share – Class A and Class B common stock subject to redemption |
| | | | — | | | | | | 0.20 | | | | | | (0.05) | | | | | | (0.06) | | | | | | (0.06) | | | | | | (0.07) | | | | | | (0.08) | | |
加权平均流通股 - A类和B类不可赎回普通股
|
| | | | — | | | | | | 3,460,275 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | — | | |
每单位的基本和稀释后净收入
share – Class A and Class B non-redeemable common stock |
| | | | — | | | | | | 0.20 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | — | | |
| | |
OneMedNet
Historical |
| |
Data
Knights Historical |
| |
Minimum
Redemption |
| |
33.33% of
Maximum Redemption |
| |
50% of
Maximum Redemption |
| |
66.67% of
Maximum Redemption |
| |
Maximum
Redemption |
| |||||||||||||||||||||
December 31, 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Weighted average shares
outstanding – Class A and Class B common stock subject to redemption |
| | | | 4,342,666 | | | | | | 8,264,526 | | | | | | 34,960,275 | | | | | | 31,127,325 | | | | | | 29,210,275 | | | | | | 27,293,225 | | | | | | 23,460,275 | | |
每单位的基本和稀释后净收入
share – Class A and Class B common stock subject to redemption |
| | | | (0.68) | | | | | | 0.44 | | | | | | (0.02) | | | | | | (0.02) | | | | | | (0.02) | | | | | | (0.02) | | | | | | (0.03) | | |
加权平均流通股 - A类和B类不可赎回普通股
|
| | | | | | | | | | 3,295,610 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
每单位的基本和稀释后净收入
share – Class A and Class B non-redeemable common stock |
| | | | | | | | | | 0.44 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Security
|
| |
Shares
|
| |
Current
Estimated Value Per Share |
| |
Current
Estimated Value |
| |
Initial Cost
|
| |
Unrealized
Profit |
| |
Unrealized
Profit Per Share |
| ||||||||||||||||||
Founder Shares
|
| | | | 6,432,886 | | | | | $ | 10.49 | | | | | $ | 67,480,974 | | | | | $ | 25,000 | | | | | $ | 67,455,974 | | | | | $ | 10.49 | | |
安置单位
|
| | | | 525,275 | | | | | $ | 10.49 | | | | | $ | 5,510,135 | | | | | $ | 5,252,750 | | | | | $ | 257,385 | | | | | $ | 0.49 | | |
私募认股权证
|
| | | | 525,275 | | | | | $ | 0.06 | | | | | $ | 32,775 | | | | | $ | — | | | | | $ | 32,775 | | | | | $ | 0.06 | | |
流动资金贷款转换权证
|
| | | | 150,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 9,359 | | | | | $ | 0.06 | | |
总计/加权平均值
|
| | | | 7,633,436 | | | | | $ | 9.57 | | | | | $ | 73,023,884 | | | | | $ | 5,277,750 | | | | | $ | 67,755,493 | | | | | $ | 8.88 | | |
Security
|
| |
Shares
|
| |
Current
Estimated Value Per Share |
| |
Current
Estimated Value |
| |
Initial
Cost |
| |
Unrealized
Profit |
| |
Unrealized
Profit Per Share |
| ||||||||||||||||||
Founder Shares
|
| | | | 6,325,000 | | | | | $ | 10.49 | | | | | $ | 66,349,250 | | | | | $ | 25,000 | | | | | $ | 66,324,250 | | | | | $ | 10.49 | | |
安置单位
|
| | | | 525,275 | | | | | $ | 10.49 | | | | | $ | 5,510,135 | | | | | $ | 5,252,750 | | | | | $ | 257,385 | | | | | $ | 0.49 | | |
私募认股权证
|
| | | | 525,275 | | | | | $ | 0.06 | | | | | $ | 32,775 | | | | | $ | — | | | | | $ | 32,775 | | | | | $ | 0.06 | | |
流动资金贷款转换权证
|
| | | | 150,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 9,359 | | | | | $ | 0.06 | | |
总计/加权平均值
|
| | | | 7,525,550 | | | | | $ | 9.55 | | | | | $ | 71,892,160 | | | | | $ | 5,277,750 | | | | | $ | 66,623,769 | | | | | $ | 8.85 | | |
Security
|
| |
Shares
|
| |
Current
Estimated Value Per Share |
| |
Current
Estimated Value |
| |
Initial
Cost |
| |
Unrealized
Profit |
| |
Unrealized
Profit Per Share |
| ||||||||||||||||||
Founder Shares
|
| | | | 5,750,000 | | | | | $ | 10.49 | | | | | $ | 60,317,500 | | | | | $ | 25,000 | | | | | $ | 60,292,500 | | | | | $ | 10.49 | | |
安置单位
|
| | | | 525,275 | | | | | $ | 10.49 | | | | | $ | 5,510,135 | | | | | $ | 5,252,750 | | | | | $ | 257,385 | | | | | $ | 0.49 | | |
私募认股权证
|
| | | | 525,275 | | | | | $ | 0.06 | | | | | $ | 32,775 | | | | | $ | — | | | | | $ | 32,775 | | | | | $ | 0.06 | | |
流动资金贷款转换权证
|
| | | | 150,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 9,359 | | | | | $ | 0.06 | | |
总计/加权平均值
|
| | | | 6,950,550 | | | | | $ | 9.48 | | | | | $ | 65,860,410 | | | | | $ | 5,277,750 | | | | | $ | 60,592,019 | | | | | $ | 8.72 | | |
| | |
共享数据骑士的所有权
|
| |||||||||||||||||||||||||||||||||||||||||||||
| | |
Pro Forma Combined
(Assuming No Further Redemptions Scenario) |
| |
Pro Forma Combined
(Assuming 80% Redemptions Scenario) |
| |
Pro Forma Combined
(Assuming Maximum Redemptions Scenario)(1) |
| |
Pro Forma Combined
(Assuming No Further Redemptions Scenario and Full Exercise of Options and Warrants) |
| ||||||||||||||||||||||||||||||||||||
Stockholder
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| ||||||||||||||||||||||||
OneMedNet前股东
|
| | | | 20,000,000 | | | | | | 57.5% | | | | | | 20,000,000 | | | | | | 57.5% | | | | | | 20,000,000 | | | | | | 62.7% | | | | | | 20,806,453 | | | | | | 51.0% | | |
Data Knights Public Stockholders(2)(4)
|
| | | | 2,731,544 | | | | | | 7.9% | | | | | | 2,300,000 | | | | | | 6.6% | | | | | | — | | | | | | —% | | | | | | 6,884,332 | | | | | | 18.6% | | |
Data Knights Sponsor
and Insiders(3) |
| | | | 7,018,161 | | | | | | 20.2% | | | | | | 6,910,275 | | | | | | 19.9% | | | | | | 6,335,275 | | | | | | 19.9% | | | | | | 7,581,123 | | | | | | 16.2% | | |
PIPE and Others
|
| | | | 5,015,485 | | | | | | 14.4% | | | | | | 5,563,514 | | | | | | 16.0% | | | | | | 5,563,514 | | | | | | 17.4% | | | | | | 5,563,514 | | | | | | 14.8% | | |
Total Shares Outstanding
|
| | | | 34,765,190 | | | | | | 100.0% | | | | | | 34,773,789 | | | | | | 100.0% | | | | | | 31,898,789 | | | | | | 100.0% | | | | | | 40,835,412 | | | | | | 100.0% | | |
Name
|
| |
Age
|
| |
Position
|
|
Paul Casey | | | 76 | | | 董事首席执行官(4) | |
Dr. Jeffrey Yu | | | 55 | | |
董事会主席、创始人,
总裁副首席医疗官(6) |
|
Lisa Embree | | | 51 | | |
总裁 - 财务副总裁临时首席财务官
|
|
Erkan Akyuz | | | 53 | | | Director(1)(2)(4) | |
Eric Casaburi | | | 48 | | | Director(5) | |
Robert Golden | | | 60 | | | Director(1)(2)(4) | |
Dr. Julianne Huh | | | 53 | | | Director(3)(5) | |
Dr. Thomas Kosasa | | | 77 | | | Director(1)(5) | |
Dr. Christoph Zindel | | | 61 | | | Director(2)(3)(6) | |
Security
|
| |
Shares
|
| |
Current
Estimated Value Per Share |
| |
Current
Estimated Value |
| |
Initial Cost
|
| |
Unrealized
Profit |
| |
Unrealized
Profit Per Share |
| ||||||||||||||||||
Founder Shares
|
| | | | 6,432,886 | | | | | $ | 10.49 | | | | | $ | 67,480,974 | | | | | $ | 25,000 | | | | | $ | 67,455,974 | | | | | $ | 10.49 | | |
安置单位
|
| | | | 525,275 | | | | | $ | 10.49 | | | | | $ | 5,510,135 | | | | | $ | 5,252,750 | | | | | $ | 257,385 | | | | | $ | 0.49 | | |
私募认股权证
|
| | | | 525,275 | | | | | $ | 0.06 | | | | | $ | 32,775 | | | | | $ | — | | | | | $ | 32,775 | | | | | $ | 0.06 | | |
流动资金贷款转换权证
|
| | | | 150,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 9,359 | | | | | $ | 0.06 | | |
总计/加权平均值
|
| | | | 7,633,436 | | | | | $ | 9.57 | | | | | $ | 73,023,884 | | | | | $ | 5,277,750 | | | | | $ | 67,755,493 | | | | | $ | 8.88 | | |
Security
|
| |
Shares
|
| |
Current
Estimated Value Per Share |
| |
Current
Estimated Value |
| |
Initial
Cost |
| |
Unrealized
Profit |
| |
Unrealized
Profit Per Share |
| ||||||||||||||||||
Founder Shares
|
| | | | 6,325,000 | | | | | $ | 10.49 | | | | | $ | 66,349,250 | | | | | $ | 25,000 | | | | | $ | 66,324,250 | | | | | $ | 10.49 | | |
安置单位
|
| | | | 525,275 | | | | | $ | 10.49 | | | | | $ | 5,510,135 | | | | | $ | 5,252,750 | | | | | $ | 257,385 | | | | | $ | 0.49 | | |
私募认股权证
|
| | | | 525,275 | | | | | $ | 0.06 | | | | | $ | 32,775 | | | | | $ | — | | | | | $ | 32,775 | | | | | $ | 0.06 | | |
流动资金贷款转换权证
|
| | | | 150,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 9,359 | | | | | $ | 0.06 | | |
总计/加权平均值
|
| | | | 7,525,550 | | | | | $ | 9.55 | | | | | $ | 71,892,160 | | | | | $ | 5,277,750 | | | | | $ | 66,623,769 | | | | | $ | 8.85 | | |
Security
|
| |
Shares
|
| |
Current
Estimated Value Per Share |
| |
Current
Estimated Value |
| |
Initial
Cost |
| |
Unrealized
Profit |
| |
Unrealized
Profit Per Share |
| ||||||||||||||||||
Founder Shares
|
| | | | 5,750,000 | | | | | $ | 10.49 | | | | | $ | 60,317,500 | | | | | $ | 25,000 | | | | | $ | 60,292,500 | | | | | $ | 10.49 | | |
安置单位
|
| | | | 525,275 | | | | | $ | 10.49 | | | | | $ | 5,510,135 | | | | | $ | 5,252,750 | | | | | $ | 257,385 | | | | | $ | 0.49 | | |
私募认股权证
|
| | | | 525,275 | | | | | $ | 0.06 | | | | | $ | 32,775 | | | | | $ | — | | | | | $ | 32,775 | | | | | $ | 0.06 | | |
流动资金贷款转换权证
|
| | | | 150,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 9,359 | | | | | $ | 0.06 | | |
总计/加权平均值
|
| | | | 6,950,550 | | | | | $ | 9.48 | | | | | $ | 65,860,410 | | | | | $ | 5,277,750 | | | | | $ | 60,592,019 | | | | | $ | 8.72 | | |
Company
|
| |
2023
EV/Revenue |
| |
2024
EV/Revenue |
| ||||||
MongoDB | | | | | 15.17 | | | | | | 11.36 | | |
Snowflake | | | | | 18.95 | | | | | | 13.01 | | |
Datadog | | | | | 20.02 | | | | | | 14.33 | | |
Doximity | | | | | 14.64 | | | | | | — | | |
Cloudflare | | | | | 26.33 | | | | | | 20.24 | | |
NextDC | | | | | 15.66 | | | | | | 12.90 | | |
4DMedical | | | | | 30.14 | | | | | | 11.02 | | |
OneMedNet | | | | | 23.20 | | | | | | 10.75 | | |
Comparison Companies
|
| |
MongoDB, Inc.
|
| |
Snowflake Inc.
|
| |
Datadog, Inc.
|
| |
Doximity, Inc.
|
| |
Cloudflare,
Inc. |
| |
NEXTDC
Limited |
| |
4DMedical
Limited |
| |
Median
|
| |
25th
Percentile |
| |
75th
Percentile |
| |||||||||||||||||||||
Industry . . . . . . . .
|
| |
Internet
Services and Infastructure |
| |
Internet
Services and Infastructure |
| |
Application
Software |
| |
Health
Care Technology |
| |
Internet
Services and Infastructure |
| |
Internet
Services and Infastructure |
| |
Health
Care Technology |
| | | | | | | | | | |||||||||||||||||||||
企业价值(单位:百万)
|
| | | $ | 24,105.37 | | | | | $ | 53,086.08 | | | | | $ | 38,678.74 | | | | | $ | 8,622.40 | | | | | $ | 19,363.24 | | | | | $ | 4,666.18 | | | | | $ | 47.45 | | | | | | | | | | | |
盈利能力 - LTM息税前利润百分比
|
| | | | -29.22% | | | | | | -47.39% | | | | | | 2.20% | | | | | | 33.50% | | | | | | -11.39% | | | | | | 52.76% | | | | | | -4979.43% | | | | | | | | | | | |
Projected Revenue (in
millions) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Calendar Year + 1
|
| | | $ | 1,193.52 | | | | | $ | 2,025.65 | | | | | $ | 1,618.67 | | | | | $ | 414.60 | | | | | $ | 958.61 | | | | | $ | 221.86 | | | | | $ | 2.73 | | | | | | | | | | | |
Calendar Year + 2
|
| | | $ | 1,562.64 | | | | | $ | 3,110.71 | | | | | $ | 2,226.06 | | | | | $ | 547.13 | | | | | $ | 1,309.25 | | | | | $ | 265.77 | | | | | $ | 8.26 | | | | | | | | | | | |
Selected Guideline
Public Companies |
| |
MongoDB, Inc.
|
| |
Snowflake Inc.
|
| |
Datadog, Inc.
|
| |
Doximity, Inc.
|
| |
Cloudflare
Inc. |
| |
NEXTDC
Limited |
| |
4DMedical
Limited |
| |
Median
|
| |
25th
Percentile |
| |
75th
Percentile |
| ||||||||||||||||||||||||||||||
Calendar Year + 3
|
| | | $ | 2,055.21 | | | | | $ | 4,559.39 | | | | | $ | 3,101.71 | | | | | $ | 705.94 | | | | | $ | 1,795.65 | | | | | $ | 344.83 | | | | | | 不适用 | | | | | | | | | | | | | | | | | | | | |
Calendar Year + 4
|
| | | $ | 2,663.71 | | | | | $ | 6,923.30 | | | | | $ | 4,332.01 | | | | | $ | 866.63 | | | | | $ | 2,776.56 | | | | | $ | 448.71 | | | | | | 不适用 | | | | | | | | | | | | | | | | | | | | |
Multiple Anaylsis | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
企业价值/总收入 -调整后的 规模
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Calendar Year + 2
|
| | | | 9.2x | | | | | | 9.2x | | | | | | 9.9x | | | | | | 9.4x | | | | | | 9.1x | | | | | | 10.4x | | | | | | 5.7x | | | | | | 9.2x | | | | | | 9.1x | | | | | | 9.7x | | |
Calendar Year + 3
|
| | | | 7.8x | | | | | | 7.3x | | | | | | 8.1x | | | | | | 8.0x | | | | | | 7.4x | | | | | | 8.8x | | | | | | 不适用 | | | | | | 7.9x | | | | | | 7.5x | | | | | | 8.1x | | |
Calendar Year + 4
|
| | | | 6.5x | | | | | | 5.5x | | | | | | 6.4x | | | | | | 7.0x | | | | | | 5.4x | | | | | | 7.4x | | | | | | 不适用 | | | | | | 6.5x | | | | | | 5.8x | | | | | | 6.9x | | |
AOP
|
| |
2021
|
| |
2022
|
| |
2023
|
| |
2024
|
| |
2025
|
| |
2026
|
| |
2027
|
| |
2028
|
| |
2029
|
| |
2030
|
| |
2031
|
| |
2032
|
| ||||||||||||||||||||||||||||||||||||
Bookings | | | | $ | 1,346.4 | | | | | $ | 4,612.0 | | | | | $ | 11,409.8 | | | | | $ | 23,811.5 | | | | | $ | 44,274.4 | | | | | $ | 61,554.1 | | | | | $ | 85,745.7 | | | | | $ | 120,043.9 | | | | | $ | 168,061.5 | | | | | $ | 235,286.1 | | | | | $ | 329,400.6 | | | | | $ | 461,160.8 | | |
YoY Growth Assumptions
|
| | |
|
29%
|
| | | |
|
243%
|
| | | |
|
147%
|
| | | |
|
109%
|
| | | |
|
86%
|
| | | |
|
39%
|
| | | |
|
39%
|
| | | |
|
40%
|
| | | |
|
40%
|
| | | |
|
40%
|
| | | |
|
40%
|
| | | |
|
40%
|
| |
Revenue | | | | $ | 1,091.8 | | | | | $ | 3,799.0 | | | | | $ | 8,620.9 | | | | | $ | 18,610.8 | | | | | $ | 35,693.2 | | | | | $ | 57,745.1 | | | | | $ | 88,177.2 | | | | | $ | 126,066.6 | | | | | $ | 167,938.7 | | | | | $ | 207,151.7 | | | | | $ | 233,941.6 | | | | | $ | 240,229.0 | | |
YoY Revenue Growth
Assumptions |
| | |
|
32%
|
| | | |
|
248%
|
| | | |
|
127%
|
| | | |
|
116%
|
| | | |
|
92%
|
| | | |
|
62%
|
| | | |
|
53%
|
| | | |
|
43%
|
| | | |
|
33%
|
| | | |
|
23%
|
| | | |
|
13%
|
| | | |
|
3%
|
| |
% of Bookings turned
to Revenue |
| | |
|
81%
|
| | | |
|
82%
|
| | | |
|
76%
|
| | | |
|
78%
|
| | | |
|
81%
|
| | | |
|
94%
|
| | | |
|
103%
|
| | | |
|
105%
|
| | | |
|
100%
|
| | | |
|
88%
|
| | | |
|
71%
|
| | | |
|
52%
|
| |
Cost of Sales
|
| | | $ | 1,205.1 | | | | | $ | 2,638.5 | | | | | $ | 3,352.9 | | | | | $ | 6,547.5 | | | | | $ | 11,791.9 | | | | | $ | 16,796.4 | | | | | $ | 25,648.2 | | | | | $ | 36,417.0 | | | | | $ | 48,030.5 | | | | | $ | 58,623.9 | | | | | $ | 64,333.9 | | | | | $ | 64,861.8 | | |
Cost of sales as % of Revenue
|
| | |
|
110%
|
| | | |
|
69%
|
| | | |
|
39%
|
| | | |
|
35%
|
| | | |
|
33%
|
| | | |
|
29%
|
| | | |
|
29%
|
| | | |
|
29%
|
| | | |
|
29%
|
| | | |
|
28%
|
| | | |
|
27%
|
| | | |
|
27%
|
| |
| | |
2021
|
| |
2022
|
| |
2023
|
| |
2024
|
| |
2025
|
| |
2026
|
| |
2027
|
| |
2028
|
| |
2029
|
| |
2030
|
| |
2031
|
| |
2032
|
| ||||||||||||||||||||||||||||||||||||
SG&A
|
| | | $ | 1,801.9 | | | | | $ | 2,131.4 | | | | | $ | 5,359.0 | | | | | $ | 7,635.0 | | | | | $ | 9,468.3 | | | | | $ | 11,189.8 | | | | | $ | 17,086.9 | | | | | $ | 25,213.3 | | | | | $ | 33,587.7 | | | | | $ | 43,087.5 | | | | | $ | 49,595.6 | | | | | $ | 50,688.3 | | |
YoY Revenue Growth
Assumptions |
| | | | | | | | |
|
18%
|
| | | |
|
151%
|
| | | |
|
42%
|
| | | |
|
24%
|
| | | |
|
18%
|
| | | |
|
53%
|
| | | |
|
48%
|
| | | |
|
33%
|
| | | |
|
28%
|
| | | |
|
15%
|
| | | |
|
2%
|
| |
R&D, Ops
|
| | | | 795.226 | | | | | $ | 1,496.7 | | | | | $ | 2,301.5 | | | | | $ | 2,700.4 | | | | | $ | 3,102.4 | | | | | $ | 3,451.4 | | | | | $ | 5,270.3 | | | | | $ | 6,933.7 | | | | | $ | 9,236.6 | | | | | $ | 10,357.6 | | | | | $ | 11,697.1 | | | | | $ | 12,011.5 | | |
YoY Revenue Growth
Assumptions |
| | | | | | | | |
|
88%
|
| | | |
|
54%
|
| | | |
|
17%
|
| | | |
|
15%
|
| | | |
|
11%
|
| | | |
|
53%
|
| | | |
|
32%
|
| | | |
|
33%
|
| | | |
|
12%
|
| | | |
|
13%
|
| | | |
|
3%
|
| |
Selected Guideline
Public Companies |
| |
MongoDB, Inc.
|
| |
Snowflake Inc.
|
| |
Datadog, Inc.
|
| |
Doximity, Inc.
|
| |
Cloudflare,
Inc. |
| |
NEXTDC
Limited |
| |
4DMedical
Limited |
| |
Median
|
| |
25th
Percentile |
| |
75th
Percentile |
| ||||||||||||||||||||||||||||||
Industry | | |
Internet
Services and Infastructure |
| |
Internet
Services and Infastructure |
| |
Application
Software |
| |
Health
Care Technology |
| |
Internet
Services and Infastructure |
| |
Internet
Services and Infastructure |
| |
Health
Care Technology |
| | | | | | | | | | | | | | | | | | | |||||||||||||||||||||
企业价值(单位:百万)
|
| | | $ | 24,105.37 | | | | | $ | 53,086.08 | | | | | $ | 38,678.74 | | | | | $ | 8,622.40 | | | | | $ | 19,363.24 | | | | | $ | 4,666.18 | | | | | $ | 47.45 | | | | | | | | | | | | | | | | | | | | |
盈利能力 - LTM息税前利润百分比
|
| | | | -29.22% | | | | | | -47.39% | | | | | | 2.20% | | | | | | 33.50% | | | | | | -11.39% | | | | | | 52.76% | | | | | | -4979.43% | | | | | | | | | | | | | | | | | | | | |
Projected Revenue (in
millions) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Calendar Year + 1
|
| | | $ | 1,193.52 | | | | | $ | 2,025.65 | | | | | $ | 1,618.67 | | | | | $ | 414.60 | | | | | $ | 958.61 | | | | | $ | 221.86 | | | | | $ | 2.73 | | | | | | | | | | | | | | | | | | | | |
Calendar Year + 2
|
| | | $ | 1,562.64 | | | | | $ | 3,110.71 | | | | | $ | 2,226.06 | | | | | $ | 547.13 | | | | | $ | 1,309.25 | | | | | $ | 265.77 | | | | | $ | 8.26 | | | | | | | | | | | | | | | | | | | | |
Calendar Year + 3
|
| | | $ | 2,055.21 | | | | | $ | 4,559.39 | | | | | $ | 3,101.71 | | | | | $ | 705.94 | | | | | $ | 1,795.65 | | | | | $ | 344.83 | | | | | | 不适用 | | | | | | | | | | | | | | | | | | | | |
Calendar Year + 4
|
| | | $ | 2,663.71 | | | | | $ | 6,923.30 | | | | | $ | 4,332.01 | | | | | $ | 866.63 | | | | | $ | 2,776.56 | | | | | $ | 448.71 | | | | | | 不适用 | | | | | | | | | | | | | | | | | | | | |
Multiple Anaylsis | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
企业价值/总收入-调整后的规模
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Calendar Year + 2
|
| | | | 9.2x | | | | | | 9.2x | | | | | | 9.9x | | | | | | 9.4x | | | | | | 9.1x | | | | | | 10.4x | | | | | | 5.7x | | | | | | 9.2x | | | | | | 9.1x | | | | | | 9.7x | | |
Calendar Year + 3
|
| | | | 7.8x | | | | | | 7.3x | | | | | | 8.1x | | | | | | 8.0x | | | | | | 7.4x | | | | | | 8.8x | | | | | | 不适用 | | | | | | 7.9x | | | | | | 7.5x | | | | | | 8.1x | | |
Calendar Year + 4
|
| | | | 6.5x | | | | | | 5.5x | | | | | | 6.4x | | | | | | 7.0x | | | | | | 5.4x | | | | | | 7.4x | | | | | | 不适用 | | | | | | 6.5x | | | | | | 5.8x | | | | | | 6.9x | | |
| | |
Charter
|
| |
拟议修订的宪章
|
|
Name Change
|
| | 数据骑士收购公司 | | | OneMedNet公司 | |
Purpose
|
| | 《数据骑士宪章》规定,数据骑士收购公司的目的是从事任何合法的行为或活动,公司可根据DGCL组织起来。除法律赋予公司的权力和特权及附带的权力和特权外,公司还拥有并可以行使进行、促进或实现公司的业务或目的所必需或方便的所有权力和特权,包括但不限于进行涉及公司和一项或多项业务的合并、股本交换、资产收购、股票购买、重组或类似的业务合并。 | | | 拟议的修订宪章规定,OneMedNet Corporation的目的是从事根据特拉华州一般公司法可为公司组织的任何合法行为或活动。 | |
Capitalization
|
| | 《数据骑士宪章》授权发行111,000,000股,包括100,000,000股A类普通股、10,000,000股B类普通股和1,000,000股优先股,每股面值0.0001美元。 | | | 拟议的修订章程取消了B类普通股,使所有类别股本的总股本为101,000,000股,其中包括100,000,000股普通股和1,000,000股优先股,每股面值为0.0001美元。 | |
A类和B类普通股重新分类
|
| | 《数据骑士宪章》授权A类普通股和B类普通股。 | | | 拟议修订的章程取消了A类普通股和B类普通股,取代了普通股 | |
董事会组成
|
| | 《数据骑士宪章》规定,除可由一名或多名持有人选出的董事外,公司董事的人数 | | | 拟议的修订章程规定,公司的董事人数为9人,可以增加或减少1人或 | |
| | |
Charter
|
| |
拟议修订的宪章
|
|
| | | 按类别或系列分开投票的优先股系列应由董事会根据董事会多数成员通过的决议不时确定。根据董事的任期,董事会分为三个相等或接近相等的级别,每一级别的任期交错三年。在每届股东年会上,被选举接替任期届满的董事的董事的任期应在他们当选后的第三次股东年会上届满。 | | | 董事会不时采纳的更多内容。董事会任期分为三级,一级在2023年召开的股东年会上任期届满,第二级在2024年召开的股东年会上任期届满,第三级在2025年召开的股东年会上任期届满。在每届年度股东大会上,被选举接替任期届满的董事的董事的任期应在他们当选后的第三次年度股东大会上届满。尽管有上述规定,被选入每一级别的董事应任职至其继任者被正式选举并合格为止,或直至其先前辞职、去世或被免职为止。如果董事人数此后发生变化,任何新增的董事职位或董事职位的减少应在各级之间进行分配,以使所有类别的董事人数在切实可行的情况下接近相等,但组成整个董事会的董事人数的减少不会缩短任何现任董事的任期。董事人数的减少不得导致董事在其任期届满前被免职。这种董事会分类可能会延迟或防止新OneMedNet的控制权或管理层发生变化,因为在大多数情况下,要求某人在两次或两次以上的年度会议上成功参与委托书竞争,才能获得董事会的控制权。 | |
Amendment of By-Laws
|
| | 《数据骑士宪章》规定,采用、修订、更改或废除本章程需获得董事会过半数成员的赞成票。公司章程也可由股东通过、修改、变更或废止;但除任何类别或 股东的任何表决外, | | | 拟议的修订章程规定,董事会有权通过、修改、更改或废除公司的章程。除适用法律或本第三修正案所要求的公司任何类别或系列股票的持有人的任何投票权外 | |
| | |
Charter
|
| |
拟议修订的宪章
|
|
| | | (Br)法律或本修订及重订证书(包括任何优先股名称)所规定的本公司一系列股本,持有本公司当时所有已发行股本中一般有权在董事选举中投票的全部已发行股本的至少过半数投票权的持有人投赞成票后,股东须通过、修订、更改或废除该等附例;但进一步规定,股东此后通过的任何章程不得使董事会先前的任何行为无效,而该等行为在该等章程未获采纳的情况下是有效的。 | | | 和重发证书(包括关于一个或多个类别或系列优先股的任何指定证书),公司股东通过、修订或废除公司章程时,必须获得当时所有已发行有表决权股票投票权的至少66%和三分之二(66-2/3%)的持有者的赞成票,作为一个类别一起投票;但公司股东此后通过的任何附例,不得使董事会先前的任何行为无效,而该等行为如果没有通过该等附例则是有效的。这一更高的审批要求可能会推迟或阻止新OneMedNet的章程发生变化,并可能具有推迟或阻止新OneMedNet的控制权或管理层发生变化的效果。 | |
Charter Amendment
|
| | 《数据骑士宪章》规定,本公司保留随时、不时地按照《数据骑士收购公司宪章》和DGCL现在或以后规定的方式,修改、更改、更改或废除其中包含的任何条款,以及当时有效的特拉华州法律授权的其他条款;除第VIII条所载者外,数据骑士收购公司授予股东、董事或任何其他人士的所有任何性质的权利、优惠及特权,均须受第XI条(公司机会)保留的权利所规限;惟第IX条(业务合并要求;存在)只可按其中所规定予以修订。 | | | 拟议的修订章程规定,持有当时所有已发行股份中至少66%和三分之二(66-2/3%)投票权的持有人作为一个单一类别一起投票时,必须获得持有该等股份的股东的赞成票,以更改、修订或废除章程第五条(董事会)、第六条(股东)、第七条(责任和赔偿;公司机会)、第八条(企业合并)、第九条(排他性论坛)和第十条(修正案)。这一更高的批准要求可能会延迟或阻止新OneMedNet宪章的这些条款的变化,从而具有延迟或阻止新OneMedNet的控制或管理变化的效果。 | |
空白支票公司专用拨备
|
| | 《数据骑士宪章》规定了与我们在完成初始业务合并之前作为一家空白支票公司的运营相关的各种条款。 | | | 拟议的修订章程删除了以前包含在数据骑士收购公司章程中的这些条款的全部内容,因为在完成业务合并后,数据骑士收购 | |
| | |
Charter
|
| |
拟议修订的宪章
|
|
| | | | | | 公司将不再是空白支票公司。此外,规定发售所得款项须存放于信托户口直至Data Knight Acquisition Corp.的业务合并或清盘为止的条文,以及管理建议业务合并完成的条款,将不适用于业务合并完成后,因此将予删除。 | |
Duration of Existence
|
| | 《数据骑士宪章》规定,如果数据骑士未能完成业务合并,并未能在首次公开募股结束后12个月内或在任何延展期内(受法律要求的限制)完成初始业务合并,数据骑士将被要求解散和清算其信托账户,将该账户中当时剩余的资金返还给公众股东,但在某些情况下,数据骑士保荐人有能力延长期限。 | | | 拟议修订的宪章删除了《数据骑士宪章》中的清盘条款,保留了《DGCL》中永久存在的默认条款 | |
Name
|
| |
Age
|
| |
Position
|
|
Barry Anderson | | | 45 | | | 董事长兼首席执行官兼董事 | |
Firdauz Edmin Bin Mokhtar | | | 49 | | | 首席财务官兼秘书 | |
Syed Musheer Ahmed | | | 38 | | | Director | |
Dr. Julianne Huh | | | 53 | | | Director | |
Annie Damit Undikai | | | 60 | | | Director | |
Patent
Number |
| |
Jurisdiction
|
| |
Anticipated
Expiration Date |
| |
Brief Description
|
|
8065166 | | |
USA
|
| |
02/21/2030
|
| | 用于将医疗文件从源医疗机构电子传输到目的地医疗机构的计算机实现的方法、计算机系统和计算机可读存储设备 | |
Patent
Number |
| |
Jurisdiction
|
| |
Anticipated
Expiration Date |
| |
Brief Description
|
|
8090596 | | |
USA
|
| |
09/12/2028
|
| | 用于以电子方式将医疗文件从源计算系统传输到目的地计算系统或从第一医疗机构传输到第二医疗机构的计算机实现的方法、计算机系统和计算机可读存储装置 | |
8099307 | | |
USA
|
| |
09/12/2028
|
| | 用于将医疗文件从源设施计算系统电子传输到目的地设施计算系统的计算机实现的方法、计算机系统和计算机可读存储装置 | |
8108228 | | |
USA
|
| |
09/12/2028
|
| | 用于将医疗文件从医疗设施的放射信息系统、医院信息系统、图像存档和通信系统、图像服务器和其他医疗系统中的至少一个电子地传输到存储设施、存储计算系统或目的地设施的计算机实现的方法、计算机系统和计算机可读存储设备 | |
8121870 | | |
USA
|
| |
09/12/2028
|
| | 用于验证和批准政府要求的放行表格的计算机实现的方法、计算机系统和计算机可读存储 | |
8131569 | | |
USA
|
| |
09/12/2028
|
| | 用于将医疗文件从源计算系统电子传输到目的地设施或目的地计算系统的计算机实现的方法、计算机系统和计算机可读存储装置 | |
8195483 | | |
USA
|
| |
09/12/2028
|
| | 用于控制将医疗文件从源设施传输到目的地设施的基于许可的工作流过程的计算机实现的方法、计算机系统和计算机可读存储装置 | |
8386278 | | |
USA
|
| |
09/12/2028
|
| | 用于将医疗文件从源医疗机构电子传输到目的地医疗机构的计算机实现的方法、计算机系统和计算机可读存储设备 | |
9171344 | | |
USA
|
| |
03/11/2033
|
| | 用于响应于经由交互式用户界面从用户接收的输入来访问一个或多个电子医疗数据源以便通过计算机网络将一个或多个医疗文件从源设施传输到目的地设施的计算机实现的方法 | |
9760677 | | |
USA
|
| |
04/23/2030
|
| | 用于医疗信息设备组件跟踪的电子方法和过程,用于响应于经由交互式用户界面接收的指令来提供对一个或多个电子医疗数据源的访问,以便传输和路由医疗数据 | |
2008318772 | | |
AUS
|
| |
10/29/2028
|
| | 用于将医疗文件从源计算系统电子传输到目的地计算系统的计算机实现的方法、计算机系统和计算机可读存储装置 | |
|
Unit Tiers
|
| |
Reseller Transfer Fee
|
| |
Annual Studies Volume
|
| ||||||||||||||||||||||||||||||
|
Unit
Tier |
| |
Min
|
| |
Max
|
| |
Unit Fee
|
| |
Set-up Fee
|
| |
Min Volume
|
| |
Max Volume
|
| ||||||||||||||||||
|
1
|
| | | | 0 | | | | | | 25 | | | | | $ | 714 | | | | | $ | 3,571 | | | | | | 0 | | | | | | 250,000 | | |
|
2
|
| | | | 26 | | | | | | 50 | | | | | $ | 696 | | | | | $ | 6,964 | | | | | | 260,000 | | | | | | 500,000 | | |
|
3
|
| | | | 51 | | | | | | 75 | | | | | $ | 679 | | | | | $ | 10,179 | | | | | | 510,000 | | | | | | 750,000 | | |
|
4
|
| | | | 76 | | | | | | 100 | | | | | $ | 661 | | | | | $ | 13,214 | | | | | | 760,000 | | | | | | 1,000,000 | | |
|
5
|
| | | | 101 | | | | | | 125 | | | | | $ | 643 | | | | | $ | 16,071 | | | | |
|
1,010,000
|
| | | | | 1,250,000 | | |
|
6
|
| | | | 126 | | | | | | 150 | | | | | $ | 625 | | | | | $ | 18,750 | | | | | | 1,260,000 | | | | | | 1,500,000 | | |
|
7
|
| | | | 151 | | | | | | 175 | | | | | $ | 607 | | | | | $ | 21,250 | | | | | | 1,510,000 | | | | | | 1,750,000 | | |
|
8
|
| | | | 176 | | | | | | 200 | | | | | $ | 589 | | | | | $ | 23,571 | | | | | | 1,760,000 | | | | | | 2,000,000 | | |
|
9
|
| | | | 201 | | | | | | 225 | | | | | $ | S71 | | | | | $ | 25,714 | | | | | | 2,010,000 | | | | | | 2,250,000 | | |
|
10
|
| | | | 226 | | | | | | 250 | | | | | $ | 554 | | | | | $ | 27,679 | | | | | | 2,260,000 | | | | | | 2,500,000 | | |
|
11
|
| | | | 251 | | | | | | 275 | | | | | $ | 536 | | | | | $ | 29,464 | | | | | | 2,510,000 | | | | | | 2,750,000 | | |
|
12
|
| | | | 276 | | | | | | 300 | | | | | $ | 518 | | | | | $ | 31,071 | | | | | | 2,760,000 | | | | | | 3,000,000 | | |
|
13
|
| | | | 301 | | | | | | 325 | | | | | $ | 500 | | | | | $ | 32,500 | | | | | | 3,010,000 | | | | | | 3,250,000 | | |
|
14
|
| | | | 326 | | | | | | 350 | | | | | $ | 482 | | | | | $ | 33,750 | | | | | | 3,260,000 | | | | | | 3,500,000 | | |
|
15
|
| | | | 351 | | | | | | 375 | | | | | $ | 464 | | | | | $ | 34,821 | | | | | | 3,510,000 | | | | | | 3,750,000 | | |
|
16
|
| | | | 376 | | | | | | 400 | | | | | $ | 446 | | | | | $ | 35,714 | | | | | | 3,760,000 | | | | | | 4,000,000 | | |
|
17
|
| | | | 401 | | | | | | 425 | | | | | $ | 429 | | | | | $ | 36,429 | | | | | | 4,010,000 | | | | | | 4,250,000 | | |
|
18
|
| | | | 426 | | | | | | 450 | | | | | $ | 411 | | | | | $ | 36,964 | | | | | | 4,260,000 | | | | | | 4,500,000 | | |
|
19
|
| | | | 451 | | | | | | 475 | | | | | $ | 393 | | | | | $ | 37,321 | | | | | | 4,510,000 | | | | | | 4,750,000 | | |
|
20
|
| | | | 476 | | | | | | 500 | | | | | $ | 375 | | | | | $ | 37,500 | | | | | | 4,760,000 | | | | | | 5,000,000 | | |
| | |
Six Months Ended
June 30, 2022 |
| |
Year Ended
December 31, 2021 |
| ||||||
Data Exchange | | | | | | | | | | | | | |
数据许可协议
|
| | | $ | 149,540 | | | | | $ | 379,479 | | |
主经销商协议
|
| | | $ | 178,974 | | | | | $ | 319,626 | | |
| | | | $ | 328,514 | | | | | $ | 699,104 | | |
| | |
Nine months
ended June 30, 2022 |
| |
Year Ended
December 31, 2021 |
| ||||||
Real World Data (iRWD) | | | | | | | | | | | | | |
AI
|
| | | | 180,664 | | | | | | 293,395 | | |
Medical Device
|
| | | | 4,950 | | | | | | 4,950 | | |
Imaging
|
| | | | 201,168 | | | | | | 94,328 | | |
| | | | | 386,782 | | | | | | 392,673 | | |
Data Exchange (Beam) | | | | | | | | | | | | | |
医院和卫生系统
|
| | | | 502,188 | | | | | | 699,104 | | |
Total Revenue
|
| | | | 888,970 | | | | | | 1,091,777 | | |
Name
|
| |
Age
|
| |
Position(s)
|
|
Paul Casey | | |
76
|
| | 董事首席执行官 | |
Dr. Jeffrey Yu | | |
55
|
| | 创始人、首席医疗官、副董事长总裁 | |
Lisa Embree | | |
51
|
| | 首席财务官总裁 - 财务副总裁 | |
Name and Principal
Position |
| |
Year
|
| |
Salary
($) |
| |
Contract
Income |
| |
RSUs
($) |
| |
Stock
Options ($) |
| |
Bonus
($) |
| |
All Other
Compensation ($) |
| |
Total
($) |
| ||||||||||||||||||||||||
Paul Casey
|
| | | | 2022 | | | | | $ | 84,545(2) | | | | | $ | 60,000(1) | | | | | $ | 585,545 | | | | | | — | | | | | | — | | | | | | 441,000(1) | | | | | $ | 585,545 | | |
| | | 2021 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 0 | | | ||
| | | 2020 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | ||
| | | 2019 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | ||
Doug Arent
|
| | | | 2022 | | | | | $ | 161,200(3) | | | | | | — | | | | | | — | | | | | | 10,000 | | | | | | — | | | | | | 46,473 | | | | | $ | 217,673 | | |
| | | 2021 | | | | | $ | 155,000(3) | | | | | | — | | | | | | — | | | | | | 10,000 | | | | | | — | | | | | | — | | | | | $ | 165,000 | | | ||
| | | 2020 | | | | | $ | 109,792(3) | | | | | | — | | | | | | — | | | | | | 100,000 | | | | | | — | | | | | | — | | | | | $ | 209,792 | | | ||
| | | 2019 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | ||
Saurabh Mathur
|
| | | | 2022 | | | | | $ | 218,750(4) | | | | | | — | | | | | | — | | | | | | 100,000 | | | | | $ | 5,000 | | | | | | — | | | | | $ | 323,750 | | |
| | | 2021 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | ||
| | | 2020 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | ||
| | | 2019 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | ||
Joseph Walsh
|
| | | | 2022 | | | | | $ | 137,500(5) | | | | | | — | | | | | | — | | | | | | 225,000 | | | | | | — | | | | | | — | | | | | $ | 362,500 | | |
| | | 2021 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | ||
| | | 2020 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | ||
| | | 2019 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | ||
David·加斯科因
|
| | | | 2022 | | | | | $ | 110,445(6) | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 132,267 | | | | | | — | | | | | $ | 242,721 | | |
| | | 2021 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | ||
| | | 2020 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | ||
| | | 2019 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | ||
Lisa Embree
|
| | | | 2022 | | | | | $ | 106,250(7) | | | | | $ | 27,231(8) | | | | | | — | | | | | | 30,000 | | | | | | — | | | | | | — | | | | | $ | 163,481 | | |
| | | 2021 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | ||
| | | 2020 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | ||
| | | 2019 | | | | | | 0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | ||
黛布拉·莱因哈特
|
| | | | 2022 | | | | | $ | 163,000(9) | | | | | | — | | | | | | — | | | | | | 54,000 | | | | | | 29,000 | | | | | | — | | | | | $ | 246,000 | | |
| | | 2021 | | | | | $ | 134,000(9) | | | | | | — | | | | | | — | | | | | | 25,000 | | | | | | — | | | | | | — | | | | | $ | 159,000 | | | ||
| | | 2020 | | | | | $ | 122,667(9) | | | | | $ | 15,050(10) | | | | | | — | | | | | | 50,000 | | | | | | — | | | | | | — | | | | | $ | 187,717 | | | ||
| | | 2019 | | | | | | 0 | | | | | $ | 109,130(10) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 109,130 | | |
Name
|
| |
Cash
($) |
| |
Equity
($) |
| |
Pension/
NQDC ($) |
| |
Perquisites/
优势 ($) |
| |
Tax
Reimbursements ($) |
| |
Other
($)(1) |
| |
Total
($) |
| |||||||||||||||||||||
Paul Casey
|
| | | | 144,000 | | | | | | — | | | | | | 0 | | | | | | — | | | | | | 0 | | | | | $ | | | | | $ | | |
Name
|
| |
Cash
($) |
| |
Equity
($) |
| |
Pension/
NQDC ($) |
| |
Perquisites/
优势 ($) |
| |
Tax
Reimbursements ($) |
| |
Other
($)(1) |
| |
Total
($) |
| |||||||||||||||||||||
Doug Arent
|
| | | | 155,000 | | | | | | — | | | | | | 0 | | | | | | — | | | | | | 0 | | | | | $ | | | | | | $ | | | |
Name
|
| |
Cash
($) |
| |
Equity
($) |
| |
Pension/
NQDC ($) |
| |
Perquisites/
优势 ($) |
| |
Tax
Reimbursements ($) |
| |
Other
($)(1) |
| |
Total
($) |
| |||||||||||||||||||||
Saurabh Mathur
|
| | | | 250,000 | | | | | | — | | | | | | 0 | | | | | | — | | | | | | 0 | | | | | $ | | | | | $ | | |
Name
|
| |
Age
|
| |
Position
|
|
Paul Casey | | | 76 | | | 董事首席执行官(4) | |
Dr. Jeffrey Yu | | | 55 | | | 董事会主席、创始人、首席医疗官总裁副董事长(6) | |
Lisa Embree | | | 51 | | | - 财务副总裁总裁首席财务官 | |
Erkan Akyuz | | | 53 | | | Director(1)(2)(4) | |
Eric Casaburi | | | 48 | | | Director(5) | |
Robert Golden | | | 60 | | | Director(1)(2)(4) | |
Dr. Julianne Huh | | | 53 | | | Director(3)(5) | |
Dr. Thomas Kosasa | | | 77 | | | Director(1)(5) | |
Dr. Christoph Zindel | | | 61 | | | Director(2)(3)(6) | |
Name
|
| |
Age
|
| |
Position
|
|
Paul Casey | | | 76 | | | 董事首席执行官 | |
Dr. Jeffrey Yu
|
| | 55 | | |
董事会主席、创始人、首席医疗官总裁副董事长
|
|
Lisa Embree | | | 51 | | | - 财务副总裁总裁首席财务官 | |
| | | | | |
企业合并后
|
| ||||||||||||||||||||||||||||||
| | |
Before the Business
Combination |
| |
Assuming No
Further Redemptions(1) |
| |
Assuming
Maximum Redemptions(2) |
| |||||||||||||||||||||||||||
受益人姓名和地址
|
| |
Number of
shares of Data Knights Common Stock |
| |
%
|
| |
Number of
shares of Data Knights Common Stock |
| |
%
|
| |
Number of
shares of Data Knights Common Stock |
| |
%
|
| ||||||||||||||||||
企业合并前的董事和高管
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Barry Anderson
|
| | | | 15,000 | | | | | | * | | | | | | 15,000 | | | | | | * | | | | | | 15,000 | | | | | | * | | |
Firdauz Edmin bin Mokhtar
|
| | | | 15,000 | | | | | | * | | | | | | 15,000 | | | | | | * | | | | | | 15,000 | | | | | | * | | |
Syed Musheer Ahmed
|
| | | | 5,000 | | | | | | * | | | | | | 5,000 | | | | | | * | | | | | | 5,000 | | | | | | * | | |
Dr. Julianne Huh
|
| | | | 5,000 | | | | | | * | | | | | | 5,000 | | | | | | * | | | | | | 5,000 | | | | | | * | | |
Annie Damit Undikai
|
| | | | 5,000 | | | | | | * | | | | | | 5,000 | | | | | | * | | | | | | 5,000 | | | | | | * | | |
所有事前合并董事和高管(5人)
|
| | | | 45,000 | | | | | | | | | | | | 45,000 | | | | | | | | | | | | 45,000 | | | | | | | | |
董事和高管业务后
Combination |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Dr. Julianne Huh
|
| | | | 5,000 | | | | | | * | | | | | | 45,000 | | | | | | * | | | | | | 45,000 | | | | | | * | | |
Paul Casey
|
| | | | | | | | | | | | | | | | 599,172 | | | | | | 11.9% | | | | | | 599,172 | | | | | | 2.6% | | |
Dr. Jeffrey Yu
|
| | | | | | | | | | | | | | | | 3,713,753 | | | | | | 10.6% | | | | | | 3,713,753 | | | | | | 15.8% | | |
Lisa Embree
|
| | | | | | | | | | | | | | | | 45,000 | | | | | | * | | | | | | 45,000 | | | | | | * | | |
Erkan Akyuz
|
| | | | | | | | | | | | | | | | 45,000 | | | | | | * | | | | | | 45,000 | | | | | | * | | |
Eric Casaburi
|
| | | | | | | | | | | | | | | | 45,000 | | | | | | * | | | | | | 45,000 | | | | | | * | | |
Robert Golden
|
| | | | | | | | | | | | | | | | 45,000 | | | | | | * | | | | | | 45,000 | | | | | | * | | |
Dr. Thomas Kosasa(1)
|
| | | | | | | | | | | | | | | | 4,952,409 | | | | | | 14.2% | | | | | | 4,952,409 | | | | | | 21.0% | | |
Dr. Christoph Zindel
|
| | | | | | | | | | | | | | | | 45,000 | | | | | | * | | | | | | 45,000 | | | | | | * | | |
所有企业合并后的董事和高管作为一个群体(10人)
|
| | | | 5,000 | | | | | | * | | | | | | 9,535,334 | | | | | | 27.3% | | | | | | 9,535,334 | | | | | | 40.6% | | |
Five Percent Holders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Data Knights, LLC(2)(3)
|
| | | | 3,415,275 | | | | | | 22.8% | | | | | | 3,415,275 | | | | | | 9.8% | | | | | | 3,415,275 | | | | | | 14.6% | | |
Jerry Hiatt
|
| | | | | | | | | | | | | | | | 1,329,058 | | | | | | 3.8% | | | | | | 1,329,058 | | | | | | 5.7% | | |
| | |
Page No.
|
| |||
数据骑士收购公司经审计的财务报表 | | | | | | | |
独立注册会计师事务所报告(PCAOB ID#688)
|
| | | | F-2 | | |
财务报表: | | | | | | | |
Balance Sheet as of December 31, 2021
|
| | | | F-3 | | |
2021年2月8日(开始)至2021年12月31日期间的经营报表
|
| | | | F-4 | | |
2021年2月8日(开始)至2021年12月31日期间股东赤字变动表
|
| | | | F-5 | | |
2021年2月8日(开始)至2021年12月31日的现金流量表
|
| | | | F-6 | | |
财务报表附注
|
| | | | F-7 | | |
数据骑士收购公司截至2022年9月30日和截至2022年9月30日的季度的未经审计简明财务报表
|
| | | | | | |
截至2022年9月30日(未经审计)和2021年12月31日的简明资产负债表
|
| | | | F-23 | | |
截至2022年9月30日和2021年9月30日的三个月、截至2022年9月30日的九个月以及2021年2月8日(初始)至2021年9月30日(未经审计)的简明运营报表
|
| | | | F-24 | | |
截至2022年9月30日的三个月和九个月、截至2021年9月30日的三个月和截至2021年9月30日的三个月以及2021年2月8日(成立)至2021年9月30日(未经审计)的股东权益变动简明报表
|
| | | | F-25 | | |
2021年2月8日(初始)至2021年9月30日期间和截至2022年9月30日的9个月(未经审计)的现金流量表简明报表
|
| | | | F-26 | | |
简明财务报表附注(未经审计)
|
| | | | F-27 | | |
OneMedNet公司经审计的财务报表 | | | | | | | |
独立注册会计师事务所报告(PCAOB ID#5041)
|
| | | | F-46 | | |
Balance Sheets as of December 31, 2021 and December 31, 2020
|
| | | | F-47 | | |
截至2021年12月31日和2020年12月31日的年度经营报表
|
| | | | F-48 | | |
截至2021年12月31日的年度股东权益变动表和
2020 |
| | | | F-49 | | |
截至2021年12月31日和2020年12月31日的年度现金流量表
|
| | | | F-50 | | |
已审计财务报表附注
|
| | | | F-51 | | |
OneMedNet公司截至及全年未经审计的简明合并财务报表
截至2022年9月30日的季度零9个月 |
| | | | | | |
截至2022年9月30日(未经审计)和12月31日的简明合并资产负债表
2021 |
| | | | F-61 | | |
截至2022年9月30日和2021年9月30日的三个月以及截至2022年9月30日和2021年9月30日的九个月的简明综合经营报表(未经审计)
|
| | | | F-62 | | |
截至2022年9月30日和2021年9月30日的9个月股东权益简明综合变动表(未经审计)
|
| | | | F-63 | | |
截至2022年9月30日和2021年9月30日的9个月简明合并现金流量表(未经审计)
|
| | | | F-64 | | |
简明财务报表附注(未经审计)
|
| | | | F-65 | | |
| | |
December 31,
2021 |
| |||
| | | | | | | |
ASSETS | | | | | | | |
Current assets | | | | | | | |
Cash
|
| | | $ | 453,151 | | |
Prepaid expense
|
| | | | 21,215 | | |
Prepaid insurance
|
| | | | 61,846 | | |
Total Current Assets
|
| | | | 536,212 | | |
信托账户中持有的现金投资
|
| | | | 117,320,973 | | |
Total assets
|
| | | $ | 117,857,185 | | |
负债和股东权益 | | | | | | | |
流动负债 | | | | | | | |
Accrued expense
|
| | | $ | 125,972 | | |
Franchise tax payable
|
| | | | 164,008 | | |
流动负债总额
|
| | | | 289,980 | | |
Warrant liability
|
| | | | 4,851,668 | | |
应付延期承销费
|
| | | | 4,025,000 | | |
Total liabilities
|
| | | | 9,166,648 | | |
承付款和或有事项 | | | | | | | |
可能赎回的A类普通股;11,500,000股,赎回价值10.20美元
|
| | | | 117,300,000 | | |
股东亏损 | | | | | | | |
优先股,面值0.0001美元;授权1,000,000股;未发行和已发行
|
| | | | — | | |
A类普通股,面值0.0001美元;授权发行1亿股;已发行和已发行股票585,275股,不包括需要赎回的11,500,000股
|
| | | | 59 | | |
B类普通股,面值0.0001美元;授权发行1,000,000股;已发行和已发行2,875,000股
|
| | | | 288 | | |
新增实收资本
|
| | | | — | | |
Accumulated deficit
|
| | | | (8,609,810) | | |
股东亏损总额
|
| | | | (8,609,463) | | |
总负债和股东亏损
|
| | | $ | 117,857,185 | | |
| | |
For the Period
from February 8, 2021 (Inception) Through December 31, 2021 |
| |||
组建和运营成本
|
| | | $ | 421,397 | | |
Franchise tax expense
|
| | | | 164,008 | | |
运营成本损失
|
| | | | (585,405) | | |
Other income (expense): | | | | | | | |
信托账户中持有的有价证券赚取的利息
|
| | | | 1,876 | | |
已实现和未实现收益
|
| | | | 19,097 | | |
权证负债公允价值变动
|
| | | | 6,325,281 | | |
分配给担保责任的报价成本
|
| | | | (625,059) | | |
Net income
|
| | | $ | 5,135,790 | | |
A类普通股赎回加权平均流通股
|
| | | | 8,264,526 | | |
普通股基本和稀释后净收益
|
| | | $ | 0.44 | | |
A类和B类不可赎回普通股加权平均流通股
|
| | | | 3,295,610 | | |
普通股基本和稀释后净收益
|
| | | $ | 0.44 | | |
| | |
Class A
Common Stock |
| |
Class B
Common Stock |
| |
Additional
Paid in Capital |
| |
Accumulative
Deficit |
| |
Total
Stockholders’ Deficit |
| |||||||||||||||||||||||||||
| | |
Shares
|
| |
Amounts
|
| |
Shares
|
| |
Amounts
|
| ||||||||||||||||||||||||||||||
Balance – February 8, 2021 (inception)
|
| | | | — | | | | | $ | — | | | | | | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
向保荐人发行B类普通股
|
| | | | — | | | | | | — | | | | | | 2,875,000 | | | | | | 288 | | | | | | 24,712 | | | | | | — | | | | | | 25,000 | | |
将不可赎回的私募单位出售给赞助商
|
| | | | 585,275 | | | | | | 59 | | | | | | — | | | | | | — | | | | | | 5,290,242 | | | | | | — | | | | | | 5,290,301 | | |
可能赎回的A类普通股重新计量
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (5,314,954) | | | | | | (13,745,600) | | | | | | (19,060,554) | | |
Net income
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 5,135,790 | | | | | | 5,135,790 | | |
Balance – December 31, 2021
|
| | | | 585,275 | | | | | $ | 59 | | | | | | 2,875,000 | | | | | $ | 288 | | | | | $ | — | | | | | $ | (8,609,810) | | | | | $ | (8,609,463) | | |
| 经营活动现金流: | | | | | | | |
|
Net income
|
| | | $ | 5,135,790 | | |
|
将净收入与经营活动中使用的净现金进行调整:
|
| | | | | | |
|
信托账户中持有的证券赚取的利息
|
| | | | (1,876) | | |
|
已实现和未实现收益
|
| | | | (19,097) | | |
|
分配给担保责任的报价成本
|
| | | | 625,059 | | |
|
经营性资产和负债变动:
|
| | | | | | |
|
Prepaid expense
|
| | | | (83,061) | | |
|
Accrued expense
|
| | | | 125,972 | | |
|
Franchise tax payable
|
| | | | 164,008 | | |
|
权证负债公允价值变动
|
| | | | (6,325,281) | | |
|
经营活动中使用的净现金
|
| | | | (378,487) | | |
| 投资活动现金流: | | | | | | | |
|
投资信托账户中持有的现金
|
| | | | (117,300,000) | | |
|
投资活动中使用的净现金
|
| | | | (117,300,000) | | |
| 融资活动的现金流: | | | | | | | |
|
向保荐人发行B类普通股所得款项
|
| | | | 25,000 | | |
|
出售单位的收益,扣除已支付的承保折扣后的净额
|
| | | | 112,700,000 | | |
|
出售私募单位的收益
|
| | | | 5,852,750 | | |
|
支付产品费用
|
| | | | (446,112) | | |
|
本票收益
|
| | | | 78,925 | | |
|
本票还款
|
| | | | (78,925) | | |
|
融资活动提供的现金净额
|
| | | | 118,131,638 | | |
|
Net change in cash
|
| | | | 453,151 | | |
|
期初现金
|
| | |
|
—
|
| |
|
期末现金
|
| | | $ | 453,151 | | |
| 补充披露非现金融资活动: | | | | | | | |
|
应付延期承销费
|
| | | $ | 4,025,000 | | |
|
权证责任的初始分类
|
| | | $ | 11,176,949 | | |
| | |
As of December 31,
2021 |
| |||
Gross Proceeds
|
| | | $ | 115,000,000 | | |
Less: | | | | | | | |
分配给公募和私募认股权证的收益
|
| | | | (10,614,500) | | |
与A类普通股相关的发行成本
|
| | | | (6,146,054) | | |
Plus: | | | | | | | |
账面价值到赎回价值的重新计量
|
| | | | 19,060,554 | | |
或有可赎回的A类普通股
|
| | | | 117,300,000 | | |
| | |
For the period of
February 8, 2021 (inception) Through December 31, 2021 |
| |||
可赎回A类普通股 | | | | | | | |
Numerator: | | | | | | | |
可分配给普通股的净收入,但有可能赎回
|
| | | $ | 3,671,658 | | |
分母:可赎回普通股的加权平均数
|
| | | | 8,264,526 | | |
每股可赎回普通股的基本和稀释后净收益
|
| | | $ | 0.44 | | |
不可赎回的A类和B类普通股 | | | | | | | |
Numerator: | | | | | | | |
可分配给不受赎回限制的普通股的净收入
|
| | | $ | 1,464,132 | | |
分母:不可赎回普通股的加权平均数
|
| | | | 3,295,610 | | |
每股不可赎回私募和普通股的基本和摊薄净亏损
|
| | | $ | 0.44 | | |
Description
|
| |
Quoted Prices in
Active Markets (Level 1) |
| |
Significant Other
Observable Inputs (Level 2) |
| |
Significant Other
Unobservable Inputs (Level 3) |
| |||||||||
Asset: | | | | | | | | | | | | | | | | | | | |
信托账户中持有的现金投资
|
| | | $ | 117,320,973 | | | | | $ | — | | | | | $ | — | | |
担保责任: | | | | | | | | | | | | | | | | | | | |
Public Warrants
|
| | | $ | 4,600,000 | | | | | $ | — | | | | | $ | — | | |
私募认股权证
|
| | | $ | — | | | | | $ | — | | | | | $ | 251,668 | | |
| | |
Warrant Liability
|
| |||
截至2021年2月8日的公允价值(开始)
|
| | | $ | — | | |
Initial measurement on May 11, 2021 (Level 3)
|
| | | | 11,176,949 | | |
Transfer to Level 1
|
| | | | (4,600,000) | | |
Change in Fair value
|
| | | | (6,325,281) | | |
Fair value as of December 31, 2021
|
| | | $ | 251,668 | | |
| | |
December 31,2021
|
| |
May 11, 2021
(Initial Measurement) |
| ||||||
| | |
(Private
Warrants) |
| |
(Public Warrants and
Private Warrants) |
| ||||||
Exercise price
|
| | | $ | 11.50 | | | | | $ | 11.50 | | |
Share price
|
| | | $ | 10.10 | | | | | $ | 10.00 | | |
Expected term (years)
|
| | | | 5.36 | | | | | | 5.75 | | |
收购概率
|
| | | | 100.0% | | | | | | 75.0% | | |
Volatility
|
| | | | 7.4% | | | | | | 17.0% | | |
Risk-free rate
|
| | | | 1.28% | | | | | | 0.97% | | |
Dividend yield (per share)
|
| | | | 0.00% | | | | | | 0.00% | | |
| | |
Private
Warrants |
| |
Public
Warrants |
| |
Total Warrant
Liability |
| |||||||||
截至2021年5月11日的公允价值(首次公开募股)
|
| | | $ | 562,449 | | | | | $ | 10,614,500 | | | | | $ | 11,176,949 | | |
估值输入或其他假设的变化(1)
|
| | | | (281,517) | | | | | | (6,014,500) | | | | | | (6,325,281) | | |
Fair value as of December 31, 2021
|
| | | $ | 251,668 | | | | | $ | 4,600,000 | | | | | $ | 4,851,668 | | |
| | |
Years Ended
December 31, 2021 |
| |||
Federal | | | | | | | |
Current
|
| | | $ | — | | |
Deferred
|
| | | | (118,531) | | |
State and Local | | | | | | | |
Current
|
| | | $ | — | | |
Deferred
|
| | | | — | | |
估值免税额变动
|
| | | | 118,531 | | |
Income tax provision
|
| | | $ | — | | |
| | |
Years Ended
December 31, 2021 |
| |||
Deferred Tax Assets | | | | | | | |
Net Operating Loss
|
| | | $ | 31,892 | | |
Sec. 195 Start-up Costs
|
| | | | 88,493 | | |
递延税金资产合计
|
| | | | 120,385 | | |
递延纳税义务 | | | | | | | |
信托账户投资未实现收益
|
| | | | (1,855) | | |
递延纳税负债合计
|
| | | | (1,855) | | |
减去:估值免税额
|
| | | | (118,531) | | |
扣除免税额后的递延纳税资产
|
| | | $ | — | | |
| | |
Years Ended
December 31, 2021 |
| |||
法定联邦所得税税率
|
| | | | 21.00% | | |
州税,扣除联邦税收优惠后的净额
|
| | | | —% | | |
衍生负债公允价值变动
|
| | | | (25.89)% | | |
分配给权证发行的交易成本
|
| | | | 2.57% | | |
估值免税额变动
|
| | | | 2.32% | | |
Income tax provision
|
| | | | —% | | |
| | |
September 30,
2022 |
| |
December 31,
2021 |
| ||||||
| | |
(Unaudited)
|
| |
(Audited)
|
| ||||||
ASSETS | | | | | | | | | | | | | |
Current assets | | | | | | | | | | | | | |
Cash
|
| | | $ | 234,923 | | | | | $ | 453,151 | | |
Prepaid expense
|
| | | | — | | | | | | 21,215 | | |
Prepaid insurance
|
| | | | — | | | | | | 61,846 | | |
Total Current Assets
|
| | |
|
234,923
|
| | | |
|
536,212
|
| |
信托账户中持有的投资
|
| | | | 120,133,869 | | | | | | 117,320,973 | | |
Total assets
|
| | | $ | 120,368,792 | | | | | $ | 117,857,185 | | |
负债和股东权益 | | | | | | | | | | | | | |
流动负债 | | | | | | | | | | | | | |
Accrued expense
|
| | | $ | 1,285,086 | | | | | $ | 125,972 | | |
应付关联方的金额
|
| | | | 11,500 | | | | | | — | | |
Income tax payable
|
| | | | 106,724 | | | | | | — | | |
Franchise tax payable
|
| | | | 50,000 | | | | | | 164,008 | | |
流动负债总额
|
| | | | 1,453,310 | | | | | | 289,980 | | |
Warrant liabilities
|
| | | | 607,775 | | | | | | 4,851,668 | | |
应付延期承销费
|
| | | | 4,025,000 | | | | | | 4,025,000 | | |
Working capital loan
|
| | | | 300,000 | | | | | | — | | |
Extension loans
|
| | | | 2,300,000 | | | | | | — | | |
Total liabilities
|
| | | | 8,686,085 | | | | | | 9,166,648 | | |
承付款和或有事项 | | | | | | | | | | | | | |
可能赎回的A类普通股;截至2022年9月30日和2021年12月31日分别为1150万股,赎回价值分别为10.40美元和10.20美元
|
| | | | 120,133,869 | | | | | | 117,300,000 | | |
股东亏损 | | | | | | | | | | | | | |
优先股,面值0.0001美元;授权1,000,000股;未发行和已发行
|
| | | | — | | | | | | — | | |
A类普通股,面值0.0001美元;授权发行1亿股;已发行和已发行股票585,275股,不包括需要赎回的11,500,000股
|
| | | | 59 | | | | | | 59 | | |
B类普通股,票面价值$0.0001;授权发行1000万股;
2,875,000 issued and outstanding |
| | | | 288 | | | | | | 288 | | |
新增实收资本
|
| | | | — | | | | | | — | | |
Accumulated deficit
|
| | | | (8,451,509) | | | | | | (8,609,810) | | |
股东亏损总额
|
| | | | (8,451,162) | | | | | | (8,609,463) | | |
总负债和股东亏损
|
| | | $ | 120,368,792 | | | | | $ | 117,857,185 | | |
| | |
For the
Three Months Ended September 30, |
| |
For the
Nine months Ended September 30, 2022 |
| |
For the Period
from February 8, 2021 (Inception) Through September 30, 2021 |
| |||||||||||||||
| | |
2022
|
| |
2021
|
| ||||||||||||||||||
| | |
(Unaudited)
|
| |
(Unaudited)
|
| |
(Unaudited)
|
| |
(Unaudited)
|
| ||||||||||||
组建和运营成本
|
| | | $ | 467,223 | | | | | $ | 98,724 | | | | | $ | 1,771,902 | | | | | $ | 170,064 | | |
Franchise tax expense
|
| | | | 52,802 | | | | | | — | | | | | | 152,802 | | | | | | — | | |
运营成本损失
|
| | | | (520,025) | | | | | | (98,724) | | | | | | (1,924,704) | | | | | | (170,064) | | |
Other income (expense): | | | | | | | | | | | | | | | | | | | | | | | | | |
已实现和未实现收益
|
| | | | 587,303 | | | | | | 2,897 | | | | | | 779,706 | | | | | | 3,691 | | |
权证负债公允价值变动
|
| | | | (113,829) | | | | | | 1,388,792 | | | | | | 4,243,893 | | | | | | 6,391,703 | | |
Non-operating expense
|
| | | | — | | | | | | — | | | | | | — | | | | | | (625,059) | | |
扣除所得税准备前的净收益(亏损)
|
| | | $ | (46,551) | | | | | $ | 1,292,965 | | | | | $ | 3,098,895 | | | | | $ | 5,600,271 | | |
所得税拨备
|
| | | | (106,724) | | | | | | — | | | | | | (106,724) | | | | | | — | | |
Net income (loss)
|
| | | $ | (153,275) | | | | | $ | 1,292,965 | | | | | $ | 2,992,171 | | | | | $ | 5,600,271 | | |
A类普通股赎回加权平均流通股
|
| | | | 11,500,000 | | | | | | 11,500,000 | | | | | | 11,500,000 | | | | | | 6,997,872 | | |
普通股基本和稀释后净收益
|
| | | $ | 0.01 | | | | | $ | 0.09 | | | | | $ | 0.20 | | | | | $ | 0.55 | | |
A类和B类不可赎回普通股加权平均流通股
|
| | | | 3,460,275 | | | | | | 3,460,275 | | | | | | 3,460,275 | | | | | | 3,231,146 | | |
普通股基本和稀释后净收益
|
| | | $ | 0.01 | | | | | $ | 0.09 | | | | | $ | 0.20 | | | | | $ | 0.55 | | |
| | |
Class A
Common Stock |
| |
Class B
Common Stock |
| |
Additional
Paid in Capital |
| |
Accumulated
Deficit |
| |
Total
Stockholders’ Deficit |
| |||||||||||||||||||||||||||
| | |
Shares
|
| |
Amounts
|
| |
Shares
|
| |
Amounts
|
| ||||||||||||||||||||||||||||||
Balance – January 1, 2022
|
| | | | 585,275 | | | | | $ | 59 | | | | | | 2,875,000 | | | | | $ | 288 | | | | | $ | — | | | | | $ | (8,609,810) | | | | | $ | (8,609,463) | | |
将A类可赎回股票的账面价值重新计量为赎回价值
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (1,150,000) | | | | | | (1,150,000) | | |
Net income
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,145,445 | | | | | | 3,145,455 | | |
Balance – June 30, 2022 (unaudited)
|
| | | | 585,275 | | | | | $ | 59 | | | | | | 2,875,000 | | | | | $ | 288 | | | | | $ | — | | | | | $ | (6,614,365) | | | | | $ | (6,614,018) | | |
将A类可赎回股票的账面价值重新计量为赎回价值
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (1,150,000) | | | | | | (1,150,000) | | |
A类普通股按赎回价值增值
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (533,869) | | | | | | (533,869) | | |
Net income
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (153,275) | | | | | | (153,275) | | |
Balance – September 30, 2022 (unaudited)
|
| | | | 585,275 | | | | | $ | 59 | | | | | | 2,875,000 | | | | | $ | 288 | | | | | $ | — | | | | | $ | (8,451,509) | | | | | $ | (8,451,162) | | |
| | |
Class A
Common Stock |
| |
Class B
Common Stock |
| |
Additional
Paid in Capital |
| |
Accumulated
Deficit |
| |
Total
Stockholders’ Equity |
| |||||||||||||||||||||||||||
| | |
Shares
|
| |
Amounts
|
| |
Shares
|
| |
Amounts
|
| ||||||||||||||||||||||||||||||
Balance – February 8, 2021 (inception)
|
| | | | — | | | | | $ | — | | | | | | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
向保荐人发行B类普通股
|
| | | | — | | | | | | — | | | | | | 2,875,000 | | | | | | 288 | | | | | | 24,712 | | | | | | — | | | | | | 25,000 | | |
首次公开发行的单位销售,扣除发行成本
|
| | | | 12,085,275 | | | | | | 1,209 | | | | | | — | | | | | | — | | | | | | 118,730,487 | | | | | | — | | | | | | 118,731,696 | | |
延期承销佣金
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (4,025,000) | | | | | | — | | | | | | (4,025,000) | | |
认股权证负债的初始公允价值
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (11,176,949) | | | | | | — | | | | | | (11,176,949) | | |
后续股票可能被赎回
|
| | | | (11,500,000) | | | | | | (1,150) | | | | | | — | | | | | | — | | | | | | (103,553,250) | | | | | | (13,745,600) | | | | | | (117,300,000) | | |
Net income
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 4,307,307 | | | | | | 4,307,307 | | |
Balance – June 30, 2021 (unaudited)
|
| | | | 585,275 | | | | | $ | 59 | | | | | | 2,875,000 | | | | | $ | 288 | | | | | $ | — | | | | | $ | (9,438,293) | | | | | $ | (9,437,946) | | |
Net income
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,292,965 | | | | | | 1,292,965 | | |
Balance – September 30, 2021 (unaudited)
|
| | | | 585,275 | | | | | $ | 59 | | | | | | 2,875,000 | | | | | $ | 288 | | | | | $ | — | | | | | $ | (8,145,328) | | | | | $ | (8,142,981) | | |
| | |
For the
Nine months Ended September 30, 2022 |
| |
For the
Period from February 8, 2021 (Inception) Through September 30, 2021 |
| ||||||
| | |
(Unaudited)
|
| |
(Unaudited)
|
| ||||||
经营活动现金流: | | | | | | | | | | | | | |
Net income
|
| | | $ | 2,992,171 | | | | | $ | 5,600,271 | | |
将净收入与经营活动中使用的净现金进行调整:
|
| | | | | | | | | | | | |
分配给认股权证负债的报价成本
|
| | | | — | | | | | | 625,059 | | |
已实现和未实现收益
|
| | | | (779,706) | | | | | | (3,691) | | |
权证负债公允价值变动
|
| | | | (4,243,893) | | | | | | (6,391,703) | | |
经营性资产和负债变动: | | | | | | | | | | | | | |
Prepaid expense
|
| | | | 83,061 | | | | | | (144,000) | | |
Accrued expense
|
| | | | 1,159,114 | | | | | | 16,132 | | |
Franchise tax payable
|
| | | | (114,008) | | | | | | — | | |
Income tax payable
|
| | | | 106,724 | | | | | | — | | |
经营活动中使用的净现金
|
| | | | (796,537) | | | | | | (297,932) | | |
投资活动现金流: | | | | | | | | | | | | | |
信托账户现金投资
|
| | | | (2,300,000) | | | | | | (117,300,000) | | |
从信托账户提取利息
|
| | | | 266,809 | | | | | | — | | |
投资活动使用的净现金
|
| | | | (2,033,191) | | | | | | (117,300,000) | | |
融资活动的现金流: | | | | | | | | | | | | | |
发行B类普通股所得款项
|
| | |
|
—
|
| | | | | 25,000 | | |
出售单位的收益,扣除已支付的承保折扣后的净额
|
| | | | — | | | | | | 112,700,000 | | |
出售私人住宅的收益
|
| | | | — | | | | | | 5,852,750 | | |
支付产品费用
|
| | | | — | | | | | | (446,112) | | |
营运资金贷款收益
|
| | | | 300,000 | | | | | | — | | |
应付关联方金额
|
| | | | 11,500 | | | | | | — | | |
延期贷款收益
|
| | | | 2,300,000 | | | | | | — | | |
融资活动提供的现金净额
|
| | | | 2,611,500 | | | | | | 118,131,638 | | |
Net change in cash
|
| | | | (218,228) | | | | | | 533,706 | | |
期初现金
|
| | | | 453,151 | | | | |
|
—
|
| |
期末现金
|
| | | $ | 234,923 | | | | | $ | 533,706 | | |
补充披露非现金融资活动: | | | | | | | | | | | | | |
可能赎回的A类普通股初始分类
|
| | | $ | — | | | | | $ | 117,300,000 | | |
可能赎回的普通股价值变动
|
| | | $ | 2,833,869 | | | | | $ | — | | |
应付延期承销费
|
| | | $ | — | | | | | $ | 4,025,000 | | |
担保责任的初始分类
|
| | | $ | — | | | | | $ | 11,176,949 | | |
| | |
For Nine
Months ended September 30, 2022 |
| |
For the Period from
February 8, 2021 (inception) through December 31, 2021 |
| ||||||
或有可赎回A类普通股 - 期初余额
|
| | | $ | 117,300,000 | | | | | $ | — | | |
Gross Proceeds
|
| | | | — | | | | | | 115,000,000 | | |
Less: | | | | | | | | | | | | | |
分配给公募和私募认股权证的收益
|
| | | | — | | | | | | (10,614,500) | | |
与A类普通股相关的发行成本
|
| | | | — | | | | | | (6,146,054) | | |
Plus: | | | | | | | | | | | | | |
账面价值到赎回价值的重新计量
|
| | | | 2,833,869 | | | | | | 19,060,554 | | |
或有可赎回A类普通股 - 期末余额
|
| | | | 120,133,869 | | | | | | 117,300,000 | | |
| | |
Three Months Ended
September 30, |
| |
Nine months
Ended September 30, 2022 |
| |
For the
Period from February 8, 2021 (inception) Through September 30, 2021 |
| |||||||||||||||
| | |
2022
|
| |
2021
|
| ||||||||||||||||||
可赎回A类普通股标的
to possible redemption |
| | | | | | | | | | | | | | | | | | | | | | | | |
分子:可分配到可赎回的收益
A类普通股受制于 possible redemption |
| | | $ | (117,823) | | | | | $ | 993,905 | | | | | $ | 2,300,089 | | | | | $ | 3,831,255 | | |
分母:可赎回A类普通股的加权平均数
|
| | | | 11,500,000 | | | | | | 11,500,000 | | | | | | 11,500,000 | | | | | | 6,997,872 | | |
每个可赎回的基本和稀释后净收益
Class A Common Stock |
| | | $ | 0.01 | | | | | $ | 0.09 | | | | | $ | 0.20 | | | | | $ | 0.55 | | |
不可赎回的A类和B类普通股
|
| | | | | | | | | | | | | | | | | | | | | | | | |
分子:可分配给不可赎回的A类和B类普通股的净收益(亏损)
|
| | | $ | (35,452) | | | | | $ | 299,060 | | | | | $ | 692,082 | | | | | $ | 1,769,016 | | |
分母:不可赎回A、B类普通股加权平均数
|
| | | | | | | | | | | | | | | | | | | | | | | | |
不可赎回的A类私募和B类普通股,基本和稀释后的
|
| | | | 3,460,275 | | | | | | 3,460,275 | | | | | | 3,460,275 | | | | | | 3,231,146 | | |
每股不可赎回普通股和B类普通股的基本和稀释后净收益
|
| | | $ | 0.01 | | | | | $ | 0.09 | | | | | $ | 0.20 | | | | | $ | 0.55 | | |
| | |
September 30, 2022
|
| |||||||||||||||
Description
|
| |
Quoted Prices in
Active Markets (Level 1) |
| |
Significant Other
Observable Inputs (Level 2) |
| |
Significant Other
Unobservable Inputs (Level 3) |
| |||||||||
Asset: | | | | | | | | | | | | | | | | | | | |
信托账户中持有的投资
|
| | | $ | 120,133,869 | | | | | $ | — | | | | | $ | — | | |
担保责任: | | | | | | | | | | | | | | | | | | | |
Public Warrants
|
| | | $ | 575,000 | | | | | $ | — | | | | | $ | — | | |
私募认股权证
|
| | | $ | — | | | | | $ | — | | | | | $ | 32,775 | | |
| | |
December 31, 2021
|
| |||||||||||||||
Description
|
| |
Quoted Prices in
Active Markets (Level 1) |
| |
Significant Other
Observable Inputs (Level 2) |
| |
Significant Other
Unobservable Inputs (Level 3) |
| |||||||||
Asset: | | | | | | | | | | | | | | | | | | | |
信托账户中持有的投资
|
| | | $ | 117,320,973 | | | | | $ | — | | | | | $ | — | | |
担保责任: | | | | | | | | | | | | | | | | | | | |
Public Warrants
|
| | | $ | 4,600,000 | | | | | $ | — | | | | | $ | — | | |
私募认股权证
|
| | | $ | — | | | | | $ | — | | | | | $ | 251,668 | | |
| | |
September 30, 2022
|
| |
December 31, 2021
|
| ||||||
| | |
(Private Warrants)
|
| |
(Private Warrants)
|
| ||||||
Exercise price
|
| | | $ | 11.50 | | | | | $ | 11.50 | | |
Share price
|
| | | $ | 10.36 | | | | | $ | 10.10 | | |
Expected term (years)
|
| | | | 5.11 | | | | | | 5.36 | | |
收购概率
|
| | | | 5.0% | | | | | | 100.0% | | |
Volatility
|
| | | | 5.4% | | | | | | 7.4% | | |
Risk-free rate
|
| | | | 3.97% | | | | | | 1.28% | | |
Dividend yield (per share)
|
| | | | 0.00% | | | | | | 0.00% | | |
| | |
Private Placement
|
| |
Public Warrant
|
| |
Warrant Liability
|
| |||||||||
Fair value as of December 31, 2021
|
| | | $ | 251,668 | | | | | $ | 4,600,000 | | | | | $ | 4,851,668 | | |
估值输入或其他假设的变化(1)
|
| | | | (218,893) | | | | | | (4,025,000) | | | | | | (4,243,893) | | |
Fair value as of September 30, 2022
|
| | | $ | 32,775 | | | | | $ | 575,000 | | | | | $ | 607,775 | | |
| | |
As of December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Assets | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
现金和现金等价物
|
| | | $ | 699,320 | | | | | $ | 79,183 | | |
扣除备抵后的应收账款
|
| | | ||||||||||
(2021 – $22,533 & 2020 – $0)
|
| | | | 91,742 | | | | | | 195,367 | | |
预付费用和其他资产
|
| | | | 42,231 | | | | | | 19,067 | | |
Total current assets
|
| | | | 833,293 | | | | | | 293,617 | | |
Non-Current assets: | | | | | | | | | | | | | |
财产和设备,净额
|
| | | | 49,767 | | | | | | 34,297 | | |
Total assets
|
| | | $ | 883,060 | | | | | $ | 327,914 | | |
负债和股东权益(亏损) | | | | | | | | | | | | | |
流动负债: | | | | | | | | | | | | | |
应付账款及应计费用
|
| | | $ | 758,815 | | | | | $ | 391,119 | | |
Deferred revenues
|
| | | | 642,350 | | | | | | 106,373 | | |
可转换本票
|
| | | | 3,350,000 | | | | | | 1,050,000 | | |
流动负债总额
|
| | | | 4,751,165 | | | | | | 1,547,492 | | |
长期负债: | | | | | | | | | | | | | |
可转换本票
|
| | | | 1,500,000 | | | | | | 1,500,000 | | |
《加拿大紧急商业贷款法案》
|
| | | | 46,897 | | | | | | 46,850 | | |
应计利息,关联方
|
| | | | 287,610 | | | | | | 93,189 | | |
Total liabilities
|
| | | | 6,585,672 | | | | | | 3,187,531 | | |
承付款和或有事项 - 见附注12 | | | | | | | | | | | | | |
股东权益(亏损) | | | | | | | | | | | | | |
A-2系列优先股,面值0.0001美元,截至2021年12月31日和2020年12月31日授权发行的4,200,000股,截至2021年12月31日和2020年12月31日已发行和已发行的3,853,797股
|
| | | | 385 | | | | | | 385 | | |
优先股A-1,面值0.0001美元,授权发行440万股
as of both December 31, 2021 and 2020, 3,204,000 shares issued and outstanding as of both December 31, 2021 and 2020 |
| | | | 320 | | | | | | 320 | | |
普通股,面值0.0001美元,截至2021年和2020年12月31日的授权股份3,000,000股,截至2021年和2020年12月31日的已发行和已发行股票分别为4,342,666股和3,834,666股
|
| | | | 434 | | | | | | 383 | | |
额外实收资本
|
| | | | 19,607,173 | | | | | | 19,509,353 | | |
Accumulated deficit
|
| | | | (25,310,924) | | | | | | (22,370,058) | | |
股东权益合计(亏损)
|
| | | | (5,702,612) | | | | | | (2,859,617) | | |
总负债和股东权益(赤字)
|
| | | $ | 883,060 | | | | | $ | 327,914 | | |
| | |
2021
|
| |
2020
|
| ||||||
Revenues
|
| | | $ | 1,091,777 | | | | | $ | 824,034 | | |
Costs of Goods Sold
|
| | | | 1,205,184 | | | | | | 611,662 | | |
Gross Margin
|
| | | | (113,407) | | | | | | 212,372 | | |
Operating expenses: | | | | | | | | | | | | | |
一般和行政
|
| | | | 1,196,712 | | | | | | 2,064,206 | | |
Operations
|
| | | | 152,461 | | | | | | 454,606 | | |
Sales and Marketing
|
| | | | 605,235 | | | | | | 318,407 | | |
研究与开发
|
| | | | 642,765 | | | | | | 307,272 | | |
总运营费用
|
| | | | 2,597,173 | | | | | | 3,144,491 | | |
Operating loss
|
| | | | (2,710,580) | | | | | | (2,932,119) | | |
Other Income (expense) | | | | | | | | | | | | | |
Interest expense, net
|
| | | | (195,381) | | | | | | (193,549) | | |
Other income (expense)
|
| | | | (34,905) | | | | | | (82,997) | | |
| | | | $ | 230,286 | | | | | $ | 110,552 | | |
Net Loss
|
| | | $ | (2,940,866) | | | | | $ | (2,821,567) | | |
| | |
Series A-2
|
| |
Series A-1
|
| | | | | | | | | | | | | |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Stockholders’
Equity |
| |||||||||||||||||||||||||||
| | |
Preferred Stock
|
| |
Preferred Stock
|
| |
Common Stock
|
| |||||||||||||||||||||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||||||
Balances, December 31, 2019
|
| | | | 3,853,797 | | | | | $ | 385 | | | | | | 3,204,000 | | | | | $ | 320 | | | | | | 3,734,666 | | | | | $ | 373 | | | | | $ | 18,902,854 | | | | | $ | (19,548,191) | | | | | $ | (644,559) | | |
普通股发行
in exchange for services |
| | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 100,000 | | | | | | 10 | | | | | | 99,990 | | | | |
|
—
|
| | | | | 100,000 | | |
股票薪酬
expense |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 506,509 | | | | | | — | | | | | | 506,509 | | |
2020 net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (2,821,567) | | | | | | (2,821,567) | | |
Balances at December 31, 2020
|
| | | | 3,853,797 | | | | | $ | 385 | | | | | | 3,204,000 | | | | | $ | 320 | | | | | | 3,834,666 | | | | | $ | 383 | | | | | $ | 19,509,353 | | | | | $ | (22,370,058) | | | | | $ | (2,859,617) | | |
发行普通股以换取服务
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | 508,000 | | | | | | 51 | | | | | | 50,749 | | | | | | | | | | | | 50,800 | | |
基于股票的薪酬费用
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 47,071 | | | | | | | | | | | | 47,071 | | |
2021 net loss
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | — | | | | | | (2,940,866) | | | | | | (2,940,866) | | |
Balance, December 31, 2021
|
| | | | 3,853,797 | | | | | $ | 385 | | | | | | 3,204,000 | | | | | $ | 320 | | | | | | 4,3242,666 | | | | | $ | 433 | | | | | $ | 19,607,173 | | | | | $ | (25,310,924) | | | | | $ | (5,702,612) | | |
| | |
2021
|
| |
2020
|
| ||||||
经营活动现金流: | | | | | | | | | | | | | |
Net (loss) income
|
| | | $ | (2,940,866) | | | | | $ | (2,821,567) | | |
将净(亏损)收入与经营活动提供的现金净额进行调整:
|
| | | | | | | | | | | | |
折旧及摊销
|
| | | | 14,466 | | | | | | 13,920 | | |
基于股票的薪酬费用
|
| | | | 97,871 | | | | | | 606,509 | | |
资产和负债变动:
|
| | | | | | | | | | | | |
Accounts receivable
|
| | | | 81,092 | | | | | | (91,892) | | |
Allowance bad debt
|
| | | | 22,533 | | | | | | — | | |
Other current assets
|
| | | | (23,164) | | | | | | (22,642) | | |
免除支付宝保障计划贷款
|
| | | | — | | | | | | (234,500) | | |
应付账款和应计费用
|
| | | | 367,696 | | | | | | 410,824 | | |
Deferred revenue
|
| | | | 535,977 | | | | | | (30,984) | | |
经营活动提供的现金净额
|
| | | $ | (1,844,395) | | | | | $ | (2,125,048) | | |
融资活动产生的现金流 | | | | | | | | | | | | | |
加拿大紧急商业贷款法案的收益
|
| | | $ | 47 | | | | | $ | 46,850 | | |
支付宝保障计划贷款收益
|
| | | | — | | | | | | 234,500 | | |
发行可转换应付本票所得款项
|
| | | | 2,494,421 | | | | | | 1,050,000 | | |
融资活动的净现金流
|
| | | | 2,494,468 | | | | | | 1,331,350 | | |
现金和现金等价物净变化
|
| | | | (620,137) | | | | | | (816,051) | | |
现金和现金等价物,从
开始
|
| | | | 79,183 | | | | | | 895,234 | | |
现金和现金等价物,结束
|
| | | $ | 699,320 | | | | | $ | 79,183 | | |
| | |
2021
|
| |
2020
|
| ||||||
工资和顾问
|
| | | | 692,415 | | | | | | 309,253 | | |
Hosting and Data
|
| | | | 508,588 | | | | | | 299,752 | | |
Other
|
| | | | 4,181 | | | | | | 2,657 | | |
| | | | | 1,205,184 | | | | | | 611,662 | | |
| 一般和行政 | | | | | | | | | | | | | |
|
工资和顾问
|
| | | | 708,814 | | | | | | 873,905 | | |
|
折旧及摊销
|
| | | | 14,466 | | | | | | 13,813 | | |
|
Insurance
|
| | | | 37,429 | | | | | | 21,927 | | |
|
专业费用(法律和审计)
|
| | | | 250,504 | | | | | | 289,021 | | |
|
Recruitment
|
| | | | — | | | | | | 15,750 | | |
|
租金、电信和办公用品
|
| | | | 84,187 | | | | | | 186,475 | | |
|
Stock compensation
|
| | | | 47,071 | | | | | | 606,509 | | |
|
Other
|
| | | | 54,241 | | | | | | 56,806 | | |
| | | | | | 1,196,712 | | | | | | 2,064,206 | | |
| Operations | | | | | | | | | | | | | |
|
工资和顾问
|
| | | | 152,461 | | | | | | 454,606 | | |
| Sales and marketing | | | | | | | | | | | | | |
|
工资和顾问
|
| | | | 472,129 | | | | | | 280,545 | | |
|
Tradeshows
|
| | | | 106,806 | | | | | | 22,755 | | |
|
Other
|
| | | | 26,300 | | | | | | 15,107 | | |
| | | | | | 605,235 | | | | | | 318,407 | | |
| 研发 | | | | ||||||||||
|
工资和顾问
|
| | | | 642,765 | | | | | | 302,059 | | |
| Other | | | | | — | | | | | | 5,213 | | |
| | | | | | 642,765 | | | | | | 307,272 | | |
| | |
2021
|
| |
2020
|
| ||||||
Computers
|
| | | $ | 202,777 | | | | | $ | 172,873 | | |
家具和设备
|
| | | | 3,785 | | | | | | 3,785 | | |
全部物业和设备
|
| | | | 206,562 | | | | | | 176,658 | | |
减去:累计折旧
|
| | | | (156,794) | | | | | | (142,361) | | |
净资产和设备
|
| | | $ | 49,767 | | | | | $ | 34,297 | | |
| | |
2021
|
| |
2020
|
| ||||||
Deferred tax assets: | | | | | | | | | | | | | |
净营业亏损结转
|
| | | $ | 5,604,237 | | | | | $ | 4,842,529 | | |
Stock compensation
|
| | | | 467,925 | | | | | | 445,731 | | |
Other
|
| | | | 51,617 | | | | | | 76,640 | | |
递延税项总资产
|
| | | | 6,123,778 | | | | | | 5,358,900 | | |
减去估值免税额
|
| | | | (6,123,778) | | | | | | (5,358,900) | | |
Net deferred tax assets
|
| | | $ | — | | | | | $ | — | | |
| | |
Options
Outstanding |
| |
Weighted-
Average Exercise Price |
| |
Aggregate
Intrinsic Value |
| |||||||||
Outstanding as of December 31, 2019
|
| | | | 2,146,000 | | | | | $ | 1.00 | | | | | $ | 2,146,000 | | |
Granted – under the Plan
|
| | | | 811,000 | | | | | | | | | | | | | | |
Exercised
|
| | | | — | | | | | | | | | | | | | | |
Cancelled
|
| | | | (962,000) | | | | | | | | | | | | | | |
Outstanding as of December 31, 2020
|
| | | | 1,995,000 | | | | | $ | 1.00 | | | | | $ | 1,995,000 | | |
Granted – under the Plan
|
| | | | 25,000 | | | | | | | | | | | | | | |
Exercised
|
| | | | — | | | | | | | | | | | | | | |
Cancelled
|
| | | | (1,072,813) | | | | | | | | | | | | | | |
Outstanding as of December 31, 2021
|
| | | | 947,187 | | | | | | | | | | | | | | |
截至2021年12月31日可行使的期权
|
| | | | 723,431 | | | | | $ | 1.00 | | | | | $ | 723,431 | | |
加权平均假设
|
| |
2021
|
| |
2010
|
| ||||||
Expected Life in Years
|
| | | | 6.08 | | | | | | 6.08% | | |
Risk-Free Interest Rate
|
| | | | 0.49% | | | | | | 0.49% | | |
预期股息收益率
|
| | | | 0.00% | | | | | | 0.00% | | |
Expected Volatility
|
| | | | 60% | | | | | | 60% | | |
加权平均假设
|
| |
2021
|
|
Expected Life in Years
|
| |
7.00
|
|
Risk-Free Interest Rate
|
| |
0.41% to 0.44%
|
|
预期股息收益率
|
| |
0.00%
|
|
Expected Volatility
|
| |
60%
|
|
| | |
September 30, 2022
|
| |
December 31, 2021
|
| ||||||
| | |
(Unaudited)
|
| |
(Audited)
|
| ||||||
Assets
|
| | | | | | | | | | | | |
Current Assets | | | | | | | | | | | | | |
现金和现金等价物
|
| | | $ | 312,330 | | | | | $ | 699,320 | | |
扣除备抵后的应收账款
(2022 & 2021 – $22,533) |
| | | | 180,387 | | | | | | 91,742 | | |
预付费用和其他资产
|
| | | | 108,485 | | | | | | 42,231 | | |
Total current assets
|
| | | | 601,202 | | | | | | 833,293 | | |
财产和设备,净额
|
| | | | 82,277 | | | | | | 49,767 | | |
Total assets
|
| | | $ | 683,479 | | | | | $ | 883,060 | | |
负债和股东权益(亏损)
|
| | | | | | | | | | | | |
流动负债 | | | | | | | | | | | | | |
应付账款及应计费用
|
| | | $ | 999,637 | | | | | $ | 758,815 | | |
Deferred revenues
|
| | | | 335,464 | | | | | | 642,350 | | |
可转换本票
|
| | | | 6,950,000 | | | | | | 3,350,000 | | |
流动负债总额
|
| | | | 8,285,101 | | | | | | 4,751,165 | | |
长期负债 | | | | | | | | | | | | | |
可转换本票
|
| | | | 1,500,000 | | | | | | 1,500,000 | | |
《加拿大紧急商业贷款法案》
|
| | | | 45,048 | | | | | | 46,897 | | |
应计利息,关联方
|
| | | | 560,248 | | | | | | 287,610 | | |
Total liabilities
|
| | | | 10,390,397 | | | | | | 6,585,672 | | |
股东权益(亏损) | | | | | | | | | | | | | |
A-2系列优先股,面值0.0001美元,授权4200,000股
和截至9月30日的3,853,797股已发行和流通股 2022 and December 31, 2021 |
| | | | 385 | | | | | | 385 | | |
优先股A-1,面值0.0001美元,授权发行440万股
截至9月30日,已发行和已发行的股票为3,204,000股 2022 and December 31, 2021 |
| | | | 320 | | | | | | 320 | | |
普通股,面值0.0001美元,截至2022年9月30日和2021年12月31日,已发行和已发行股票为4,342,666股,授权股份为30,000,000股
|
| | | | 434 | | | | | | 434 | | |
额外实收资本
|
| | | | 19,659,927 | | | | | | 19,607,173 | | |
Accumulated deficit
|
| | | | (29,367,984) | | | | | | (25,310,924) | | |
股东权益合计(亏损)
|
| | | | (9,706,918) | | | | | | (5,702,612) | | |
总负债和股东权益(赤字)
|
| | | $ | 683,479 | | | | | $ | 883,060 | | |
| | |
For the Three Months Ended
September 30 |
| |
For the Nine Months Ended
September 30 |
| ||||||||||||||||||
| | |
FY22
|
| |
FY21
|
| |
FY22
|
| |
FY21
|
| ||||||||||||
Revenue
|
| | | $ | 375,092 | | | | | $ | 197,105 | | | | | $ | 888,970 | | | | | $ | 693,091 | | |
Cost of Revenue
|
| | | | 473,949 | | | | | | 280,535 | | | | | | 1,106,285 | | | | | | 838,306 | | |
Gross Margin
|
| | | | (98,857) | | | | | | (83,431) | | | | | | (217,315) | | | | | | (145,215) | | |
运营费用 | | | | | | | | | | | | | | | | | | | | | | | | | |
一般和行政
|
| | | | 748,647 | | | | | | 368,837 | | | | | | 2,034,938 | | | | | | 925,417 | | |
Operations
|
| | | | 141,807 | | | | | | 26,599 | | | | | | 203,529 | | | | | | 115,433 | | |
Sales & Marketing
|
| | | | 257,231 | | | | | | 93,640 | | | | | | 588,292 | | | | | | 325,597 | | |
研发
|
| | | | 336,007 | | | | | | 173,053 | | | | | | 710,362 | | | | | | 493,005 | | |
总运营费用
|
| | | | 1,483,692 | | | | | | 662,129 | | | | | | 3,537,121 | | | | | | 1,859,453 | | |
Operating loss
|
| | | | (1,582,549) | | | | | | (745,560) | | | | | | (3,754,436) | | | | | | (2,004,668) | | |
Other Expense (income) | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense
|
| | | | 108,526 | | | | | | 59,288 | | | | | | 272,682 | | | | | | 132,948 | | |
Other expense (income)
|
| | | | 9,641 | | | | | | (800) | | | | | | 29,942 | | | | | | 18,845 | | |
| | | | | 118,167 | | | | | | 58,488 | | | | | | 302,624 | | | | | | 151,793 | | |
Net loss
|
| | | $ | (1,700,716) | | | | | $ | (804,048) | | | | | $ | (4,057,060) | | | | | $ | (2,156,461) | | |
| | |
Series A-2
Preferred Stock |
| |
Series A-1
Preferred Stock |
| |
Common Stock
|
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Stockholders’
Equity |
| ||||||||||||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||||||
Balances, December 31, 2020
|
| | | | 3,853,797 | | | | | $ | 385 | | | | | | 3,204,000 | | | | | $ | 320 | | | | | | 3,834,666 | | | | | $ | 383 | | | | | $ | 19,509,353 | | | | | $ | (22,370,058) | | | | | $ | (2,859,617) | | |
在交易所发行普通股
for services |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | 508,000 | | | | | | 51 | | | | | | 50,749 | | | | | | | | | | | | 50,800 | | |
基于股票的薪酬费用
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 143,086 | | | | | | | | | | | | 143,086 | | |
2021 Q3 YTD net loss
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (2,156,461) | | | | | | (2,156,461) | | |
Balances, September 30, 2021
|
| | | | 3,853,797 | | | | | $ | 385 | | | | | | 3,204,000 | | | | | $ | 320 | | | | | | 4,342,666 | | | | | $ | 434 | | | | | $ | 19,703,188 | | | | | $ | (24,526,519) | | | | | $ | (4,822,192) | | |
在交易所发行普通股
for services |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
基于股票的薪酬费用
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (96,015) | | | | | | | | | | | | (96,015) | | |
2021 Q4 net loss
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (784,405) | | | | | | (784,405) | | |
Balances, December 31, 2021
|
| | | | 3,853,797 | | | | | $ | 385 | | | | | | 3,204,000 | | | | | $ | 320 | | | | | | 4,342,666 | | | | | $ | 434 | | | | | $ | 19,607,173 | | | | | $ | (25,310,924) | | | | | $ | (5,702,612) | | |
基于股票的薪酬费用
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 52,754 | | | | | | | | | | | | 52,754 | | |
2022 Q3 YTD net loss
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (4,057,060) | | | | | | (4,057,060) | | |
Balances, September 30, 2022
|
| | | | 3,853,797 | | | | | $ | 385 | | | | | | 3,204,000 | | | | | $ | 320 | | | | | | 4,342,666 | | | | | $ | 434 | | | | | $ | 19,659,927 | | | | | $ | (29,367,984) | | | | | $ | (9,706,918) | | |
| | |
For the Nine Months Ended
September 30 |
| |||||||||
| | |
2022
|
| |
2021
|
| ||||||
经营活动的现金流 | | | | | | | | | | | | | |
Net Loss
|
| | | $ | (4,057,060) | | | | | $ | (2,156,461) | | |
将净亏损与经营活动的现金流量净额进行调整:
|
| | | | | | | | | | | | |
折旧及摊销
|
| | | | 16,256 | | | | | | 11,216 | | |
基于股票的薪酬费用
|
| | | | 52,754 | | | | | | 193,886 | | |
资产和负债变动:
|
| | | | | | | | | | | | |
Accounts Receivable
|
| | | | (88,645) | | | | | | 103,316 | | |
Allowance Bad Debt
|
| | | | | | | | | | | | |
Other current assets
|
| | | | (66,254) | | | | | | (133,894) | | |
免除支付宝保障计划贷款
|
| | | | | | | | | | | | |
应付账款及应计费用
|
| | | | 240,822 | | | | | | 288,100 | | |
Deferred revenue
|
| | | | (306,886) | | | | | | 89,140 | | |
经营活动的净现金流
|
| | | | (4,209,013) | | | | | | (1,604,697) | | |
用于投资活动的现金 | | | | | | | | | | | | | |
购置物业和设备
|
| | | | (48,766) | | | | | | (18,550) | | |
融资活动产生的现金流 | | | | | | | | | | | | | |
加拿大紧急商业贷款法案的收益
|
| | | | (1,849) | | | | | | 502 | | |
发行可转换应付本票所得款项
|
| | | | 3,872,638 | | | | | | 2,031,988 | | |
融资活动的净现金流
|
| | | | 3,870,789 | | | | | | 2,032,490 | | |
现金和现金等价物净变化
|
| | | | (386,990) | | | | | | 409,243 | | |
现金和现金等价物,从
开始
|
| | | | 699,320 | | | | | | 79,183 | | |
现金和现金等价物,结束
|
| | | $ | 312,330 | | | | | $ | 488,426 | | |
| | |
For the Nine Months Ended
September 30 |
| |||||||||
| | |
FY22
|
| |
FY21
|
| ||||||
Cost of Revenue | | | | | | | | | | | | | |
工资和顾问
|
| | | | 685,749 | | | | | | 518,410 | | |
托管和数据
|
| | | | 420,535 | | | | | | 319,896 | | |
| | | | | 1,106,285 | | | | | | 838,306 | | |
| 一般和行政 | | | | | | | | | | | | | |
|
工资和顾问
|
| | | | 698,826 | | | | | | 537,996 | | |
|
折旧和摊销
|
| | | | 16,060 | | | | | | 10,340 | | |
|
Insurance
|
| | | | 29,828 | | | | | | 28,264 | | |
|
专业费用(法律和审计)
|
| | | | 170,859 | | | | | | 126,930 | | |
|
与去空格相关的费用
|
| | | | 540,000 | | | | | | — | | |
|
Recruitment
|
| | | | 350,000 | | | | | | — | | |
|
租金、电信和办公用品
|
| | | | 75,132 | | | | | | 55,269 | | |
|
股票薪酬
|
| | | | 53,893 | | | | | | 141,949 | | |
|
Travel
|
| | | | 63,082 | | | | | | 1,804 | | |
|
Other
|
| | | | 37,258 | | | | | | 22,865 | | |
| | | | | | 2,034,938 | | | | | | 925,417 | | |
| Operations | | | | ||||||||||
|
工资和顾问
|
| | | | 203,529 | | | | | | 115,433 | | |
| Sales and marketing | | | | ||||||||||
|
工资和顾问
|
| | | | 559,625 | | | | | | 312,523 | | |
|
Tradeshows
|
| | | | 28,667 | | | | | | 13,074 | | |
| | | | | | 588,292 | | | | | | 325,597 | | |
| 研发 | | | | ||||||||||
|
工资和顾问
|
| | | | 710,362 | | | | | | 493,005 | | |
|
Computers
|
| | | $ | 251,543 | | |
|
家具和设备
|
| | | | 3,785 | | |
|
全部物业和设备
|
| | | | 255,328 | | |
|
减去:累计折旧
|
| | | | (173,051) | | |
|
净资产和设备
|
| | | $ | 82,277 | | |
| Deferred Tax Assets | | | | | | | |
|
净营业亏损结转
|
| | | $ | 5,800,666 | | |
|
Stock Compensation
|
| | | $ | 469,915 | | |
|
Other
|
| | | | 69,571 | | |
|
总递延税金资产
|
| | | | 6,340,152 | | |
|
减去估值免税额
|
| | | | (6,340,152) | | |
|
Net deferred tax assets
|
| | | $ | — | | |
| | |
Options
Outstanding |
| |
Weighted –
Average Exercise Price |
| |
Aggregate
Intrinsic Value |
| |||||||||
Outstanding as of December 31, 2020
|
| | | | 1,995,000 | | | | | $ | 1.00 | | | | | $ | 1,995,000 | | |
Granted – under the Plan
|
| | | | — | | | | | | | | | | | | | | |
Exercised
|
| | | | — | | | | | | | | | | | | | | |
Cancelled
|
| | | | (574,000) | | | | | | | | | | | | | | |
Outstanding as of September 30, 2021
|
| | | | 1,421,000 | | | | | $ | 1.00 | | | | | $ | 1,421,000 | | |
Granted – under the Plan
|
| | | | 25,000 | | | | | | | | | | | | | | |
Exercised
|
| | | | — | | | | | | | | | | | | | | |
Cancelled
|
| | | | (498,816) | | | | | | | | | | | | | | |
Outstanding as of December 31, 2021
|
| | | | 947,184 | | | | | $ | 1.00 | | | | | $ | 947,184 | | |
Granted – under the Plan
|
| | | | 577,000 | | | | | | | | | | | | | | |
Exercised
|
| | | | — | | | | | | | | | | | | | | |
Cancelled
|
| | | | (299,018) | | | | | | | | | | | | | | |
Outstanding as of September 30, 2022
|
| | | | 1,225,166 | | | | | $ | 1.00 | | | | | $ | 1,225,166 | | |
| | |
2022
|
| |
2021
|
| ||||||
Expected life in years
|
| | | | 6.08 | | | | | | 6.08 | | |
Risk-free interest rate
|
| | | | 0.49% | | | | | | 0.49% | | |
预期股息收益率
|
| | | | 0.00% | | | | | | 0.00% | | |
Expected volatility
|
| | | | 60% | | | | | | 60% | | |
| | |
Page
|
| |||
ARTICLE I. MERGER
|
| | | | A-2 | | |
1.1.
Merger
|
| | | | A-2 | | |
1.2.
交易生效时间
|
| | | | A-2 | | |
1.3.
Effect of the Merger
|
| | | | A-2 | | |
1.4.
Tax Treatment
|
| | | | A-2 | | |
1.5.
公司注册证书和章程
|
| | | | A-3 | | |
1.6.
交易存续公司董事及高级职员
|
| | | | A-3 | | |
1.7.
Merger Consideration
|
| | | | A-3 | | |
1.8.
公司股票折算
|
| | | | A-3 | | |
1.9.
Treasury Stock
|
| | | | A-4 | | |
1.10.
Rights Cease to Exist
|
| | | | A-4 | | |
1.11.
Dissenting Shares
|
| | | | A-4 | | |
1.12.
交出公司证券并支付合并对价
|
| | | | A-4 | | |
1.13.
交易对合并子股的影响
|
| | | | A-5 | | |
1.14.
Closing Calculations
|
| | | | A-6 | | |
1.15.
合并对价调整
|
| | | | A-6 | | |
1.16.
采取必要行动;进一步行动
|
| | | | A-7 | | |
1.17.
评估和持不同政见者权利
|
| | | | A-7 | | |
1.18.
修改后的买方注册证书
|
| | | | A-8 | | |
ARTICLE II. CLOSING
|
| | | | A-8 | | |
2.1.
Closing
|
| | | | A-8 | | |
第三条.买方的陈述和保证
|
| | | | A-8 | | |
3.1.
组织和地位
|
| | | | A-8 | | |
3.2.
授权;有约束力的协议
|
| | | | A-9 | | |
3.3.
政府审批
|
| | | | A-9 | | |
3.4.
Non-Contravention
|
| | | | A-9 | | |
3.5.
Capitalization
|
| | | | A-10 | | |
3.6.
美国证券交易委员会备案和买方财务
|
| | | | A-10 | | |
3.7.
未发生某些更改
|
| | | | A-11 | | |
3.8.
Compliance with Laws
|
| | | | A-12 | | |
3.9.
Actions; Orders; Permits
|
| | | | A-12 | | |
3.10.
Taxes and Returns
|
| | | | A-12 | | |
3.11.
员工和员工福利计划
|
| | | | A-12 | | |
3.12.
Properties
|
| | | | A-12 | | |
3.13.
Material Contracts
|
| | | | A-12 | | |
3.14.
与子公司的交易
|
| | | | A-13 | | |
3.15.
Merger Sub Activities
|
| | | | A-13 | | |
3.16.
Investment Company Act
|
| | | | A-13 | | |
3.17.
Finders and Brokers
|
| | | | A-13 | | |
3.18.
股东合并对价的所有权
|
| | | | A-13 | | |
| | |
Page
|
| |||
3.19.
某些商业惯例
|
| | | | A-13 | | |
3.20.
Insurance
|
| | | | A-14 | | |
3.21.
买方信托帐户
|
| | | | A-14 | | |
3.22.
独立调查
|
| | | | A-14 | | |
第四条.公司的陈述和保证
|
| | | | A-15 | | |
4.1.
组织和地位
|
| | | | A-15 | | |
4.2.
授权;有约束力的协议
|
| | | | A-15 | | |
4.3.
Capitalization
|
| | | | A-16 | | |
4.4.
Subsidiaries
|
| | | | A-17 | | |
4.5.
政府审批
|
| | | | A-17 | | |
4.6.
Non-Contravention
|
| | | | A-17 | | |
4.7.
Financial Statements
|
| | | | A-18 | | |
4.8.
未发生某些更改
|
| | | | A-19 | | |
4.9.
Compliance with Laws
|
| | | | A-19 | | |
4.10.
Company Permits
|
| | | | A-19 | | |
4.11.
Litigation
|
| | | | A-19 | | |
4.12.
Material Contracts
|
| | | | A-19 | | |
4.13.
知识产权
|
| | | | A-21 | | |
4.14.
Taxes and Returns
|
| | | | A-23 | | |
4.15.
Real Property
|
| | | | A-24 | | |
4.16.
Personal Property
|
| | | | A-25 | | |
4.17.
资产的所有权和充分性
|
| | | | A-25 | | |
4.18.
Employee Matters
|
| | | | A-25 | | |
4.19.
Benefit Plans
|
| | | | A-26 | | |
4.20.
环境问题
|
| | | | A-28 | | |
4.21.
与关联人的交易
|
| | | | A-28 | | |
4.22.
Insurance
|
| | | | A-28 | | |
4.23.
Books and Records
|
| | | | A-29 | | |
4.24.
顶级客户和供应商
|
| | | | A-29 | | |
4.25
某些商业惯例
|
| | | | A-29 | | |
4.26.
遵守隐私法、隐私政策和某些合同
|
| | | | A-29 | | |
4.27.
Investment Company Act
|
| | | | A-30 | | |
4.28.
Finders and Brokers
|
| | | | A-30 | | |
4.29.
独立调查
|
| | | | A-30 | | |
4.30.
Information Supplied
|
| | | | A-30 | | |
4.31.
Disclosure
|
| | | | A-31 | | |
ARTICLE V. COVENANTS
|
| | | | A-31 | | |
5.1.
Access and Information
|
| | | | A-31 | | |
5.2.
公司业务行为
|
| | | | A-32 | | |
5.3.
买方的业务行为
|
| | | | A-34 | | |
5.4.
年度和中期财务报表
|
| | | | A-37 | | |
5.5.
买方公开申报文件
|
| | | | A-37 | | |
| | |
Page
|
| |||
5.6.
No Solicitation
|
| | | | A-37 | | |
5.7.
No Trading
|
| | | | A-38 | | |
5.8.
某些事项的通知
|
| | | | A-38 | | |
5.9.
Efforts
|
| | | | A-38 | | |
5.10.
Tax Matters
|
| | | | A-40 | | |
5.11.
Further Assurances
|
| | | | A-40 | | |
5.12.
注册声明
|
| | | | A-40 | | |
5.13.
公司股东大会
|
| | | | A-41 | | |
5.14.
Public Announcements
|
| | | | A-42 | | |
5.15.
机密信息
|
| | | | A-42 | | |
5.16.
文档和信息
|
| | | | A-43 | | |
5.17.
关闭后的董事会和执行干事
|
| | | | A-43 | | |
5.18.
高级管理人员和董事的赔偿;尾部保险
|
| | | | A-44 | | |
5.19.
Trust Account Proceeds
|
| | | | A-44 | | |
5.20.
PIPE Investment
|
| | | | A-45 | | |
第六条.生存和赔偿
|
| | | | A-46 | | |
6.1.
Survival
|
| | | | A-46 | | |
第七条.成交条件
|
| | | | A-46 | | |
7.1.
各方的义务条件
|
| | | | A-46 | | |
7.2.
公司义务的条件
|
| | | | A-47 | | |
7.3.
买方义务的条件
|
| | | | A-48 | | |
7.4.
条件的挫败感
|
| | | | A-49 | | |
第八条终止合同和费用
|
| | | | A-49 | | |
8.1.
Termination
|
| | | | A-49 | | |
8.2.
Effect of Termination
|
| | | | A-50 | | |
8.3.
Fees and Expenses
|
| | | | A-51 | | |
第九条。豁免和释放
|
| | | | A-51 | | |
9.1.
放弃对信托的索赔
|
| | | | A-51 | | |
ARTICLE X. MISCELLANEOUS
|
| | | | A-52 | | |
10.1.
Notices
|
| | | | A-52 | | |
10.2.
绑定效果;分配
|
| | | | A-53 | | |
10.3.
Third Parties
|
| | | | A-53 | | |
10.4.
Arbitration
|
| | | | A-53 | | |
10.5.
管辖法律;管辖
|
| | | | A-54 | | |
10.6.
WAIVER OF JURY TRIAL
|
| | | | A-54 | | |
10.7.
Specific Performance
|
| | | | A-55 | | |
10.8.
Severability
|
| | | | A-55 | | |
10.9.
Amendment
|
| | | | A-55 | | |
10.10.
Waiver
|
| | | | A-55 | | |
10.11.
Entire Agreement
|
| | | | A-55 | | |
10.12.
Interpretation
|
| | | | A-55 | | |
| | |
Page
|
| |||
10.13.
Counterparts
|
| | | | A-56 | | |
10.14.
采购商代表
|
| | | | A-56 | | |
10.15.
销售商代表
|
| | | | A-57 | | |
10.16.
Legal Representation
|
| | | | A-59 | | |
ARTICLE XI. DEFINITIONS
|
| | | | A-59 | | |
11.1.
Certain Definitions
|
| | | | A-59 | | |
11.2.
Section References
|
| | | | A-68 | | |
Exhibit
|
| |
Description
|
|
Exhibit A | | | 投票协议格式 | |
Exhibit B | | | 赞助商支持协议格式 | |
Exhibit C | | | 锁定协议格式 | |
Exhibit D | | | 竞业禁止和竞业禁止协议格式 | |
Exhibit E | | | 提交函格式 | |
Exhibit F | | | 股权激励计划表格 | |
Exhibit G | | | 注册权协议格式 | |
Exhibit H | | | 延期托管协议 | |
|
如果在成交时或之前发给买方或合并子公司,则收件人:
数据骑士收购公司
Unit G6, Frome Business Park, Manor Road, Frome, BA11 4FN United Kingdom Attn: Barry Anderson Telephone No.: 44 203 833 4000 电子邮件:barry@dataknight sauk.com |
| |
将副本(不会构成通知)发送给:
Nelson Mullins Riley&Scarborough LLP
101 Constitution Avenue, NW, Suite 900 Washington, DC 20001 Attn: Andrew M. Tucker, Esq. Facsimile No.: (202) 689-2860 Telephone No.: (202) 689-2987 电子邮件:andy.tucker@nelsonmullins.com |
|
|
如果致买方代表,致:
Data Knights, LLC
c/o数据骑士收购公司 Unit G6, Frome Business Park, Manor Road, Frome, BA11 4FN United Kingdom Attn: Barry Anderson Telephone No.: 44 203 833 4000 电子邮件:barry@dataknight sauk.com |
| |
将副本(不会构成通知)发送给:
Nelson Mullins Riley&Scarborough LLP
101 Constitution Avenue, NW, Suite 900 Washington, DC 20001 Attn: Andrew M. Tucker, Esq. Facsimile No.: (202) 689-2860 Telephone No.: (202) 689-2987 电子邮件:andy.tucker@nelsonmullins.com |
|
|
如致本公司或尚存公司,则致:
OneMedNet Corporation
6385 Old Shady Oak Road Suite 250 Eden Prairie, Minnesota 55344 Attn: Paul Casey Telephone No.: 800-918-7189 邮箱:paul.Casey@onemednet.com |
| |
将副本(不会构成通知)发送给:
Rimon, P.C.
1990 K Street, NW Suite 420 Washington, D.C. 20006 联系人:黛比·克利斯;黛布拉·弗农 Telephone No.: 202-971-9494
E-mail:
debbie.klis@rimonlaw.com;debra.vernon@rimonlaw.com
|
|
|
如果给卖方代表:
Paul Casey
c/o OneMedNet Corporation 6385 Old Shady Oak Road Suite 250 Eden Prairie, Minnesota 55344 Telephone No.: 800-918-7189 邮箱:paul.Casey@onemednet.com |
| |
将副本(不会构成通知)发送给:
Rimon, P.C.
1990 K Street, NW Suite 420 Washington, D.C. 20006 联系人:黛比·克利斯;黛布拉·弗农 Telephone No.: 202-971-9494
E-mail:
debbie.klis@rimonlaw.com;debra.vernon@rimonlaw.com
|
|
|
如果在成交后致买方,则致:
OneMedNet Corporation
6385 Old Shady Oak Road Suite 250 Eden Prairie, Minnesota 55344 Attn: Paul Casey Telephone No.: 800-918-7189 邮箱:paul.Casey@onemednet.com and 买方代表 |
| |
将副本(不会构成通知)发送给:
Rimon, P.C.
1990 K Street, NW Suite 420 Washington, D.C. 20006 联系人:黛比·克利斯;黛布拉·弗农 Telephone No.: 202-971-9494 电子邮件:debbie.kis@rimonlaw.com; debra.vernon@rimonlaw.com and Nelson Mullins Riley&Scarborough LLP 101 Constitution Avenue, NW, Suite 900 Washington, DC 20001 Attn: Andrew M. Tucker, Esq. Facsimile No.: (202) 689-2860 Telephone No.: (202) 689-2987 电子邮件:andy.tucker@nelsonmullins.com |
|
Term
|
| |
Section
|
|
应收账款 | | | 4.7(f) | |
收购方案 | | | 5.6(a) | |
Agreement | | | Preamble | |
替代交易 | | | 5.6(a) | |
修改后的买方注册证书 | | | 1.19 | |
Antitrust Laws | | | 5.9(b) | |
经审计的公司财务报表 | | | 4.7(a) | |
业务组合 | | | 9.1 | |
合并证 | | | 1.2 | |
CFO | | | 1.15(a) | |
Term
|
| |
Section
|
|
Closing | | | 2.1 | |
Closing Date | | | 2.1 | |
Closing Filing | | | 5.14(b) | |
闭幕新闻稿 | | | 5.14(b) | |
Closing Statement | | | 1.15(a) | |
Company | | | Preamble | |
公司福利计划 | | | 4.19(a) | |
公司证书 | | | 1.12(a) | |
Company Directors | | | 5.17(a) | |
公司披露明细表 | | | Article IV | |
Company Financials | | | 4.7(a) | |
Company IP | | | 4.13(d) | |
Company IP Licenses | | | 4.13(a) | |
公司材料合同 | | | 4.12(a) | |
Company Permits | | | 4.10 | |
公司个人财产租赁 | | | 4.16 | |
公司不动产租赁 | | | 4.15 | |
公司注册IP | | | 4.13(a) | |
公司特别会议 | | | 5.13 | |
Controlled Person | | | Article XI | |
Conversion | | | 1.8 | |
D&O赔付人员 | | | 5.18(a) | |
D&O Tail Insurance | | | 5.18(b) | |
DGCL | | | 3.2 | |
Effective Time | | | 1.2 | |
可执行性例外情况 | | | 3.2 | |
环境许可证 | | | 4.20(a) | |
预估结束语 | | | 1.14 | |
Exchange Agent | | | 1.12(a) | |
Expenses | | | 8.3 | |
Extension | | | 5.3(a) | |
Extension Expenses | | | 5.3(a)(iv) | |
联邦证券法 | | | 5.7 | |
Incentive Plan | | | 5.12(a) | |
Independent Expert | | | 1.15(b) | |
独立专家通知日期 | | | 1.15(b) | |
中期资产负债表日期 | | | 4.7(a) | |
Interim Period | | | 5.1(a) | |
递送函 | | | 1.12(a) | |
Lock-Up Agreement | | | Recitals | |
遗失证书宣誓书 | | | 1.12(d) | |
Merger | | | Recitals | |
合并考虑因素 | | | 1.7 | |
Term
|
| |
Section
|
|
Merger Sub | | | Preamble | |
Nelson Mullins | | | 2.1 | |
竞业禁止协议 | | | Recitals | |
异议声明 | | | 1.15(b) | |
OFAC | | | 3.19(c) | |
现成软件 | | | 4.13(a) | |
Outbound IP License | | | 4.13(c) | |
Outside Date | | | 8.1(b) | |
Party(ies) | | | Preamble | |
PIPE Investment | | | 5.20 | |
收盘后买方板块 | | | 5.17(a) | |
Proxy Statement | | | 5.12(a) | |
公共认证 | | | 3.6(a) | |
公共股东 | | | 9.1 | |
Purchaser | | | Preamble | |
Purchaser Director | | | 5.17(a) | |
买方披露明细表 | | | Article III | |
采购员财务 | | | 3.6(b) | |
买方材料合同 | | | 3.13(a) | |
采购商代表 | | | Preamble | |
买方股东审批事项 | | | 5.12(a) | |
采购员特别会议 | | | 5.12(a) | |
买方终止费 | | | 8.4 | |
Redemption | | | 5.12(a) | |
注册声明 | | | 5.12(a) | |
Related Person | | | 4.21 | |
Released Claims | | | 9.1 | |
代表党 | | | 1.15(b) | |
需要公司股东批准 | | | 7.1(b) | |
需要买方股东批准 | | | 7.1(a) | |
SEC Reports | | | 3.6(a) | |
Section 409A Plan | | | 4.19(j) | |
销售商代表 | | | Preamble | |
Signing Filing | | | 5.14(b) | |
签署新闻稿 | | | 5.14(b) | |
赞助商支持协议 | | | Recitals | |
股东合并考虑事项 | | | 1.7 | |
幸存的公司 | | | 1.1 | |
Top Customers | | | 4.24 | |
Top Suppliers | | | 4.24 | |
递送文件 | | | 1.12(b) | |
Voting Agreements | | | Recitals | |
| |
Company Stockholder
|
| | |
Company Securities
|
| |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| 如果在成交前发给买方,收件人: | | |
将副本发送至(不构成通知):
|
|
|
数据骑士收购公司
Unit G6, Frome Business Park, Manor Road, Frome, BA11 4FN, United Kingdom Tel: +44 203 833 4000 电子邮件:barry@dataknight sauk.com |
| |
Nelson Mullins Riley&Scarborough LLP
101 Constitution Avenue, NW, Suite 900 Washington, D.C. 20001 Attn: Andrew M. Tucker, Esq. Facsimile No.: (202) 689-2860 Telephone No.: (202) 689-2987 邮箱:andy.tucker@nelsonmullins.com |
|
|
如果致本公司(或成交后致买方),致:
|
| |
将副本发送至(不构成通知):
|
|
|
OneMedNet Corporation
6385 Old Shady Oak Road Suite 250 Eden Prairie, Minnesota 55344 Attn: Paul Casey Telephone No.: (808) 228-5998 邮箱:paul.Casey@onemednet.com |
| |
Rimôn, P.C.
1990 K Street NW, Suite 420 Washington, D.C. 20006 联系人:黛比·克利斯;黛布拉·弗农 Telephone: (202) 971-9494; (650) 292-5910 电子邮件:debbie.kis@rimonlaw.com; debra.vernon@rimonlaw.com |
|
By: |
|
|
如果在成交后致买方,则致:
|
| | 将副本发送至(不构成通知): | |
|
数据骑士收购公司
商务园G6单元, Manor Road, Frome, BA11 4FN, United Kingdom Tel: +44 203 833 4000 电子邮件:barry@dataknight sauk.com |
| |
Nelson Mullins Riley&Scarborough LLP
101 Constitution Avenue, NW, Suite 900 Washington, D.C. 20001 Attn: Andrew M. Tucker, Esq. Telephone No.: (202) 689-2987 邮箱:andy.tucker@nelsonmullins.com |
|
Name of Holder: |
|
| If to Escrow Agent: | | |
Truist Bank
Attn: Escrow Services 919 East Main Street, 2nd Floor Richmond, Virginia 23219 客户经理:查尔斯·亨德森 Phone: (804) 782-7087 邮箱:Charles.Henderson@Truist.com |
|
| If to the Purchaser: | | |
数据骑士收购公司
Unit G6, Frome Business Park, Manor Road, Frome, BA11 4FN, United Kingdom Tel: +44 203 833 4000 电子邮件:barry@dataknight sauk.com |
|
| If to the Company: | | |
OneMedNet Corporation
6385 Old Shady Oak Road Suite 250 Eden Prairie, Minnesota 55344 Attn: Paul Casey
Telephone No.: (800) 918-7189
|
|
| Name: | | | Phone #1: | | | Phone #2: | |
| Title: | | | Email #1: | | | Email #2: | |
| Sign: | | | Fax: | | | Account View Access (Y/N): | |
| Notes: 1 | | | Notes: | | | Notes: | |
| Name: | | | Phone #1: | | | Phone #2: | |
| Title: | | | Email #1: | | | Email #2: | |
| Sign: | | | Fax: | | | Account View Access (Y/N): | |
| Notes: 1 | | | Notes: | | | Notes: | |
| Name: | | | Phone #1: | | | Phone #2: | |
| Title: | | | Email #1: | | | Email #2: | |
| Sign: | | | Fax: | | | Account View Access (Y/N): | |
| Notes: 1 | | | Notes: | | | Notes: | |
| Name: | | | Phone #1: | | | Phone #2: | |
| Title: | | | Email #1: | | | Email #2: | |
| Sign: | | | Fax: | | | Account View Access (Y/N): | |
| Notes: | | | Notes: | | | Notes: | |
NOTE
|
| |
特殊说明(如权限限制)
|
|
1
|
| | 授权执行管理文件中设想的所有客户操作。 | |
2
|
| | | |
3
|
| | | |
|
|
| |
Signature
|
| |
Title
|
|
| Name: | | | Phone #1: | | | Phone #2: | |
| Title: | | | Email #1: | | | Email #2: | |
| Sign: | | | Fax: | | | Account View Access (Y/N): | |
| Notes: 1 | | | Notes: | | | Notes: | |
| Name: | | | Phone #1: | | | Phone #2: | |
| Title: | | | Email #1: | | | Email #2: | |
| Sign: | | | Fax: | | | Account View Access (Y/N): | |
| Notes: 1 | | | Notes: | | | Notes: | |
| Name: | | | Phone #1: | | | Phone #2: | |
| Title: | | | Email #1: | | | Email #2: | |
| Sign: | | | Fax: | | | Account View Access (Y/N): | |
| Notes: 1 | | | Notes: | | | Notes: | |
| Name: | | | Phone #1: | | | Phone #2: | |
| Title: | | | Email #1: | | | Email #2: | |
| Sign: | | | Fax: | | | Account View Access (Y/N): | |
| Notes: | | | Notes: | | | Notes: | |
NOTE
|
| |
特殊说明(如权限限制)
|
|
1
|
| | 授权执行管理文件中设想的所有客户操作。 | |
2
|
| | | |
3
|
| | | |
|
|
| |
Signature
|
| |
Title
|
|
Exhibit No.
|
| |
Description
|
|
2.1 | | |
数据骑士、合并子公司、赞助商、OneMedNet和Paul Casey之间于2022年4月25日签署的合并协议和计划。(1)
|
|
3.1 | | |
第二次修订和重新颁发的公司注册证书。(2)
|
|
3.2 | | | 第三次修订及重订公司注册证书表格(载于委托书/招股章程附件B)。 | |
3.3 | | |
Bylaws.(3)
|
|
3.4** | | | 合并证书格式 | |
4.1 | | |
Specimen Unit Certificate.(4)
|
|
4.2 | | |
A类普通股证书样本。(5)
|
|
4.3 | | |
保证书样本。(6)
|
|
4.4 | | |
大陆股票转让与信托公司与本公司签订的担保协议,日期为2021年5月6日。(7)
|
|
5.1* | | |
Nelson Mullins Riley&Scarborough LLP的意见。
|
|
8.1* | | | Nelson Mullins Riley&Scarborough对某些税务问题的意见。 | |
10.1 | | |
本公司、初始证券持有人以及本公司高级管理人员和董事之间于2021年5月6日签署的信函协议。(8)
|
|
10.2 | | |
大陆股票转让信托公司与本公司签订的投资管理信托账户协议,日期为2021年5月6日。(9)
|
|
10.3 | | |
本公司与初始证券持有人签订的登记权协议,日期为2021年5月6日。(10)
|
|
10.4 | | |
注册人和数据骑士有限责任公司于2021年5月6日签订的配售单元购买协议(11)
|
|
10.5 | | |
赔偿协议格式。(12)
|
|
10.6 | | |
公司和数据骑士有限责任公司签订的行政支持协议,日期为2021年5月7日。(13)
|
|
10.7 | | |
本公司与Benchmark Investments LLC的分公司EF Hutton签署的承销协议日期为2021年5月6日。(14)
|
|
10.8 | | |
2022年股权激励计划表格(包括在委托书/招股说明书附件C中)。
|
|
10.9 | | |
投票协议格式(作为委托书/招股说明书附件A的附件A)。
|
|
10.10 | | |
保荐人支持协议格式(作为委托书/招股说明书附件A的附件B)。
|
|
10.11 | | |
锁定协议格式(作为委托书/招股说明书附件A的附件C)。
|
|
10.12 | | |
竞业禁止和竞业禁止协议表格(作为委托书/招股说明书附件A附件D)。
|
|
10.13 | | |
注册权协议格式(作为委托书/招股说明书附件A的附件G)。
|
|
10.14 | | |
延期托管协议(作为委托书/招股说明书附件A附件F)。
|
|
10.15** | | | 与保罗·凯西签订的高管聘用协议 | |
10.16** | | | 与道格·阿伦特的雇佣协议 | |
10.17** | | | 与Saurabh Mathur的雇佣协议 | |
10.18* | | |
日期为2021年9月16日的数据许可协议
|
|
10.19* | | |
Master Reseller Agreement dated May 22, 2015
|
|
14.1 | | |
Code of Ethics.(15)
|
|
21.1* | | |
List of Subsidiaries.
|
|
23.1 | | |
Consent of Marcum LLP
|
|
23.2* | | |
Nelson Mullins Riley&Scarborough LLP同意(作为附件5.1的一部分)。
|
|
Exhibit No.
|
| |
Description
|
|
23.3 | | |
Consent of BF Borgers CPA PC
|
|
23.4 | | |
马歇尔·史蒂文斯交易咨询服务有限责任公司同意
|
|
24.1* | | |
授权书(包含在本注册声明的签名页上)。
|
|
99.1 | | |
股东代理卡格式。
|
|
99.2* | | |
尔坎·阿克尤兹同意将其命名为董事。
|
|
99.3* | | |
Eric Casaburi同意将其命名为董事。
|
|
99.4* | | |
罗伯特·戈登同意被命名为董事。
|
|
99.5* | | |
Julianne Huh博士同意命名为董事
|
|
99.6* | | |
托马斯·科萨萨博士同意将其命名为董事
|
|
99.7* | | |
克里斯托夫·津德尔博士同意将其命名为董事
|
|
101.SCH* | | | XBRL分类扩展架构文档。 | |
101.CAL*
|
| | XBRL分类扩展计算链接库文档。 | |
101.DEF*
|
| | XBRL分类扩展定义Linkbase文档。 | |
101.LAB* | | | XBRL分类扩展标签Linkbase文档。 | |
101.PRE* | | | XBRL分类扩展演示文稿Linkbase文档。 | |
107*
|
| |
Filing Fee Table
|
|
|
Name
|
| |
Position
|
| |
Date
|
|
|
/s/ Barry Anderson
Barry Anderson
|
| |
董事首席执行官
(首席执行官) |
| |
February 3, 2023
|
|
|
/s/ Firdauz Edmin Bin Mokhtar
Firdauz Edmin Bin Mokhtar
|
| |
Chief Financial Officer
(首席财务会计官) |
| |
February 3, 2023
|
|
|
/s/ Julianne Hu*
Julianne Hu
|
| | Director | | |
February 3, 2023
|
|
|
/s/ Syed Musheer Ahmed*
Syed Musheer Ahmed
|
| | Director | | |
February 3, 2023
|
|
|
/s/ Annie Damit Undikai*
Annie Damit Undikai
|
| | Director | | |
February 3, 2023
|
|
|
*By:
/s/ Barry Anderson
Barry Anderson
Attorney-in-fact |
| | |